The University of Chicago Header Logo

David T. Rubin

TitleProfessor
InstitutionUniversity of Chicago
DepartmentMedicine
AddressChicago IL 60637
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. David T. Rubin is Chief of the Section of Gastroenterology, Hepatology & Nutrition and the Co-Director of the Digestive Diseases Center at The University of Chicago Medicine. Dr. Rubin earned a medical degree with honors at The University of Chicago Pritzker School of Medicine. He completed his residency in internal medicine and fellowships in gastroenterology and clinical medical ethics at the University of Chicago, where he served as Chief Resident and Chief Fellow. Prior to his current appointments, Dr. Rubin served for 11 years as Director of the Gastroenterology, Hepatology and Nutrition fellowship program. He also currently serves as an associate faculty member at the MacLean Center for Clinical Medical Ethics and an associate investigator at the University of Chicago Comprehensive Cancer Center.

    Dr. Rubin is a Fellow of the American Gastroenterological Association (AGA), the American College of Gastroenterology (ACG), the American Society for Gastrointestinal Endoscopy (ASGE) and the American College of Physicians (ACP) and an active national member of the Crohn’s & Colitis Foundation (CCF), and is on the Board of Trustees for the ACG. Among numerous awards and honors, Dr. Rubin was chosen by his peers as a member of Best Doctors (recognized for superior clinical ability) and America’s Top Physicians (gastroenterology). Additionally, he twice received the ACG’s Governor’s Award of Excellence in Clinical Research (2003 and 2013), the Cancer Research Foundation Young Investigator’s Award (2004), and the UC Postgraduate Teaching Award in recognition of significant contributions for fellowship education (2006). In 2012, he received the CCF Rosenthal Award, a national leadership award bestowed upon a volunteer who has contributed in an indisputable way to the quality of life of patients and families. He is currently the Chair-elect of the National Scientific Advisory Committee of the CCF. He is an Associate Editor of the journal Gastroenterology and Co-Editor of the ACG On-Line Educational Universe.

    Dr. Rubin is the editor of a best-selling book on inflammatory bowel disease (IBD), now in its 3rd edition, and an author or coauthor of many peer-reviewed articles on treatment and management of IBD, cancer in IBD and novel paradigms, as well as the first author of the in progress ACG Guidelines for ulcerative colitis. His current research is in the area of progressive complications from uncontrolled inflammation, the doctor-patient relationship in IBD, and a variety of collaborative studies related to the microbiome and intestinal disease. He is also a featured media contact for issues related to IBD, appearing on satellite radio, television, print media and maintains a popular twitter feed @IBDMD (>9500 followers). His principal research interests include novel IBD therapies and outcomes, colon cancer prevention, and clinical medical ethics.

    Collapse Biography 
    Collapse education and training
    University of Chicago Pritzker School of Medicine, ChicagoFellowship06/2001Gastroenterology
    University of Chicago Pritzker School of Medicine, ChicagoResidency06/1997Internal Medicine
    University of Chicago Pritzker School of Medicine, ChicagoMD06/1994
    University of Illinois, Urbana-ChampaignBS06/1990Honors Biology

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Posner H, Lombard R, Akiyama S, Cohen NA, Rubin DT, Dubinsky MC, Dalal S, Kayal M. Extensive Disease and Exposure to Multiple Biologics Precolectomy Is Associated with Endoscopic Cuffitis Post-Ileal Pouch-Anal Anastomosis in Patients With Ulcerative Colitis. Inflamm Bowel Dis. 2024 Mar 23. PMID: 38521548.
      Citations:    Fields:    
    2. Shahub S, Kumar RM, Lin KC, Banga I, Choi NK, Garcia NM, Muthukumar S, Rubin DT, Prasad S. Continuous Monitoring of CRP, IL-6, and Calprotectin in Inflammatory Bowel Disease Using a Perspiration-Based Wearable Device. Inflamm Bowel Dis. 2024 Mar 23. PMID: 38520737.
      Citations:    Fields:    
    3. Peyrin-Biroulet L, Panaccione R, Louis E, Atreya R, Rubin DT, Lindsay JO, Siffledeen J, Lukin DJ, Wright J, Watanabe K, Ford S, Remple VP, Lacerda AP, Dubcenco E, Garrison A, Zhou Q, Berg S, Anyanwu SI, Schreiber S, Ford S, Remple VP, Lacerda AP, Dubcenco E, Garrison A, Zhou Q, Berg S, Anyanwu SI. Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure. Clin Gastroenterol Hepatol. 2024 Mar 15. PMID: 38492904.
      Citations:    Fields:    
    4. Akiyama S, Miyatani Y, Rubin DT. The evolving understanding of histology as an endpoint in ulcerative colitis. Intest Res. 2024 Mar 13. PMID: 38475998.
      Citations:    
    5. Axelrad JE, Rubin DT. The Management of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2024 Feb 29. PMID: 38432648.
      Citations:    Fields:    
    6. Danese S, Panaccione R, Abreu MT, Rubin DT, Ghosh S, Dignass A, Afzali A, Wolf DC, Chiorean MV, Vermeire S, Jain A, Charles L, Lawlor G, Osterman MT, Wu H, Canavan JB, Petersen AK, Colombel JF, Regueiro M, Danese S, Panaccione R, Abreu MT, Rubin DT, Dignass A, Wolf DC, Chiorean MV, Vermeire S, Jain A, Charles L, Lawlor G, Osterman MT, Wu H, Petersen A, Colombel JF, Regueiro M. Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension. J Crohns Colitis. 2024 Feb 26; 18(2):264-274. PMID: 37651686; PMCID: PMC10896634.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    7. Zamani M, Ebrahimtabar F, Alizadeh-Tabari S, Kasner SE, Elkind MSV, Ananthakrishnan AN, Choden T, Rubin DT, Malekzadeh R. Risk of Common Neurological Disorders in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2024 Jan 25. PMID: 38271615.
      Citations:    Fields:    
    8. Rubin DT, Torres J, Regueiro M, Reinisch W, Prideaux L, Kotze PG, Tan FH, Gardiner S, Mundayat R, Cadatal MJ, Ng SC. Association Between Smoking Status and the Efficacy and Safety of Tofacitinib in Patients with Ulcerative Colitis. Crohns Colitis 360. 2024 Jan; 6(1):otae004. PMID: 38425446; PMCID: PMC10904100.
      Citations:    
    9. Krugliak Cleveland N, St-Pierre J, Kellar A, Rubin DT. Clinical Application of Intestinal Ultrasound in Inflammatory Bowel Disease. Curr Gastroenterol Rep. 2024 Feb; 26(2):31-40. PMID: 38243153.
      Citations:    Fields:    Translation:Humans
    10. Malter L, Hong SJ, Lopatin S, Murphy M, Hudesman D, Kane S, Rubin DT. Increasing Exposure to Inflammatory Bowel Diseases Education in Gastroenterology Fellowship: The Pilot IBD 101 Experience. Inflamm Bowel Dis. 2024 Jan 13. PMID: 38217539.
      Citations:    Fields:    
    11. Sands BE, Schreiber S, Blumenstein I, Chiorean MV, Ungaro RC, Rubin DT, Sands BE, Chiorean MV, Ungaro RC, Rubin DT. Clinician's Guide to Using Ozanimod for the Treatment of Ulcerative Colitis. J Crohns Colitis. 2023 Dec 30; 17(12):2012-2025. PMID: 37436357; PMCID: PMC10798866.
      Citations: 2     Fields:    Translation:Humans
    12. Miyatani Y, Choi D, Choi NK, Rubin DT. Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease. Dig Dis Sci. 2024 Feb; 69(2):355-359. PMID: 38112840.
      Citations:    Fields:    Translation:Humans
    13. Danese S, Panaccione R, Feagan BG, Afzali A, Rubin DT, Sands BE, Reinisch W, Panés J, Sahoo A, Terry NA, Chan D, Han C, Frustaci ME, Yang Z, Sandborn WJ, Hisamatsu T, Andrews JM, D'Haens GR, GALAXI-1 Study Group. Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial. Lancet Gastroenterol Hepatol. 2024 Feb; 9(2):133-146. PMID: 38104569.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    14. Mullowney MW, Fiebig A, Schnizlein MK, McMillin M, Koval J, Rubin D, Dalal S, Sogin ML, Chang EB, Sidebottom AM, Crosson S, Mullowney MW, Fiebig A, Schnizlein MK, McMillin M, Rose AR, Koval J, Rubin D, Dalal S, Sogin ML, Chang EB, Sidebottom AM, Crosson S, Fiebig A, Schnizlein MK, Rose AR, Crosson S. Microbially-catalyzed conjugation of GABA and tyramine to bile acids. bioRxiv. 2023 Dec 13. PMID: 37808758; PMCID: PMC10557584.
      Citations:    
    15. Cohen NA, Choi D, Garcia N, Choi NK, Picker E, Krugliak Cleveland N, Cohen RD, Dalal SR, Pekow J, Rubin DT. Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center. Dig Dis Sci. 2024 Feb; 69(2):579-587. PMID: 38087126.
      Citations:    Fields:    Translation:Humans
    16. Chavannes M, Kysh L, Allocca M, Krugliak Cleveland N, Dolinger MT, Robbins TS, Rubin DT, Sagami S, Verstockt B, Novak K. Role of artificial intelligence in imaging and endoscopy for the diagnosis, monitoring and prognostication of inflammatory bowel disease: a scoping review protocol. BMJ Open Gastroenterol. 2023 12 11; 10(1). PMID: 38081777; PMCID: PMC10729253.
      Citations:    Fields:    Translation:Humans
    17. Zinger A, Choi D, Choi N, Cohen RD, Rubin DT, Zinger A, Choi D, Choi N, Cohen RD, Rubin DT, Rubin DT. Risankizumab Effectiveness and Safety in Crohn's Disease: Real-world Data From a Large Tertiary Center. Clin Gastroenterol Hepatol. 2023 Dec 07. PMID: 38065372.
      Citations:    Fields:    
    18. Krugliak Cleveland N, Miyatani Y, Picker EA, Rubin DT. At-home Disease Monitoring by Patient-performed Intestinal Ultrasound in Severe Ulcerative Colitis. Inflamm Bowel Dis. 2023 Dec 05; 29(12):1997-1998. PMID: 37843049.
      Citations:    Fields:    Translation:Humans
    19. Rubin DT. Highlights in Crohn's Disease From the American College of Gastroenterology (ACG) 2023 Annual Scientific Meeting: Commentary. Gastroenterol Hepatol (N Y). 2023 Dec; 19(12 Suppl 8):23-27. PMID: 38444457; PMCID: PMC10910453.
      Citations:    
    20. Schreiber S, Rubin DT, Ng SC, Peyrin-Biroulet L, Danese S, Modesto I, Guo X, Su C, Kwok KK, Jo H, Chen Y, Yndestad A, Reinisch W, Dubinsky MC, Rubin DT, Danese S. Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme. J Crohns Colitis. 2023 Nov 24; 17(11):1761-1770. PMID: 37402275; PMCID: PMC10673809.
      Citations:    Fields:    Translation:Humans
    21. Peyrin-Biroulet L, Arenson E, Rubin DT, Siegel CA, Lee S, Laroux FS, Zhou W, Finney-Hayward T, Sanchez Gonzalez Y, Shields AL, Stephen Laroux F. A Comparative Evaluation of the Measurement Properties of Three Histological Indices of Mucosal Healing in Ulcerative Colitis: Geboes Score, Robarts Histopathology Index and Nancy Index. J Crohns Colitis. 2023 Nov 24; 17(11):1733-1743. PMID: 37225135; PMCID: PMC10673803.
      Citations: 1     Fields:    Translation:Humans
    22. Zhao Y, Zhou R, Xie B, Liu CY, Kalski M, Cham CM, Koval J, Weber CR, Rubin DT, Sogin M, Crosson S, Huang J, Fiebig A, Dalal S, Chang EB, Basu A, Pott S. Multiomic analysis reveals cellular and epigenetic plasticity in intestinal pouches of ulcerative colitis patients. medRxiv. 2023 Nov 13. PMID: 38014192; PMCID: PMC10680893.
      Citations:    
    23. Raine T, Ishiguro Y, Rubin DT, Finney-Hayward T, Vladea R, Liu J, Phillips C, Cheng E, Targownik L, Loftus EV. Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: a Post Hoc Analysis of the Phase 3 Clinical Trial Programme. J Crohns Colitis. 2023 Nov 06. PMID: 37942921.
      Citations: 1     Fields:    
    24. Rubin DT, Torres J, Dotan I, Xu LT, Modesto I, Woolcott JC, Gardiner S, Sands BE. An Insight into Patients' Perspectives of Ulcerative Colitis Flares via Analysis of Online Public Forum Posts. Inflamm Bowel Dis. 2023 Nov 02. PMID: 37934789.
      Citations:    Fields:    
    25. Danese S, Tran J, D'Haens G, Rubin DT, Aoyama N, Zhou W, Ilo D, Yao X, Sanchez Gonzalez Y, Panaccione R. Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data. Inflamm Bowel Dis. 2023 11 02; 29(11):1723-1729. PMID: 36790041; PMCID: PMC10628919.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    26. Krugliak Cleveland N, Ghosh S, Chastek B, Bancroft T, Candela N, Fan T, Umashankar K, Rubin DT. Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY. Inflamm Bowel Dis. 2023 Oct 31. PMID: 37921344.
      Citations:    Fields:    
    27. Cohen NA, Weber CR, Cheng JX, Choi D, Garcia NM, Choi NK, Rubin DT. Ozanimod-Exposed Patients with Ulcerative Colitis Undergoing Total Colectomy Exhibit Unique Lymph Node Histologic Changes. J Crohns Colitis. 2023 Oct 25. PMID: 37879626.
      Citations:    Fields:    
    28. Singh S, Velayos FS, Rubin DT, Singh S, Velayos FS, Rubin DT. Common Instances of Low-value Care in Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2023 Oct 23. PMID: 37879517.
      Citations:    Fields:    
    29. Vieujean S, Lindsay JO, D'Amico F, Ahuja V, Silverberg MS, Sood A, Yamamoto-Furusho JK, Nagahori M, Watanabe M, Koutroubakis IE, Foteinogiannopoulou K, Avni Biron I, Walsh A, Outtier A, Nordestgaard RLM, Abreu MT, Dubinsky M, Siegel C, Louis E, Dotan I, Reinisch W, Danese S, Rubin DT, Peyrin-Biroulet L. Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases (IBD): Real World Results from the International Organization for the study of IBD. J Crohns Colitis. 2023 Oct 21. PMID: 37864829.
      Citations:    Fields:    
    30. D'Amico F, Solitano V, Magro F, Olivera PA, Halfvarson J, Rubin D, Dignass A, Al Awadhi S, Kobayashi T, Queiroz NSF, Calvo M, Kotze PG, Ghosh S, Peyrin-Biroulet L, Danese S. Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus. J Clin Med. 2023 Oct 03; 12(19). PMID: 37834994; PMCID: PMC10574001.
      Citations: 1     
    31. Choi DK, Cohen NA, Choden T, Cohen RD, Rubin DT. Delays in Therapy Associated With Current Prior Authorization Process for the Treatment of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 10 03; 29(10):1658-1661. PMID: 36715294.
      Citations: 2     Fields:    Translation:Humans
    32. Yau YK, Wong SH, Guo CL, Ip M, Ng SC, Lau LHS, Lui RNS, Mak JWY, Ching JYL, Kamm MA, Rubin DT, Chan PKS, Chan FKL. Long-Term Safety Outcomes of Fecal Microbiota Transplantation: Real-World Data Over 8 Years From the Hong Kong FMT Registry. Clin Gastroenterol Hepatol. 2024 Mar; 22(3):611-620.e12. PMID: 37734581.
      Citations: 1     Fields:    Translation:HumansCells
    33. Jamil OK, Shaw D, Deng Z, Dinardi N, Fillman N, Khanna S, Krugliak Cleveland N, Sakuraba A, Weber CR, Cohen RD, Dalal S, Jabri B, Rubin DT, Pekow J. Inflammation in the proximal colon is a risk factor for the development of colorectal neoplasia in inflammatory bowel disease patients with primary sclerosing cholangitis. Therap Adv Gastroenterol. 2023; 16:17562848231184985. PMID: 37692199; PMCID: PMC10486214.
      Citations:    
    34. Evaristo G, Szczepanski J, Farag MS, Rubin DT, Campbell LK, Marcus VA, Lamps LW, Hart J. Crohn's Disease Features in Anastomotic Biopsies from Patients With and Without Crohn's Disease: Diagnostic and Prognostic Value. Mod Pathol. 2023 Nov; 36(11):100325. PMID: 37660927.
      Citations:    Fields:    Translation:Humans
    35. Peyrin-Biroulet L, Allegretti JR, Rubin DT, Bressler B, Germinaro M, Huang KG, Shipitofsky N, Zhang H, Wilson R, Han C, Feagan BG, Sandborn WJ, Panés J, Hisamatsu T, Lichtenstein GR, Sands BE, Dignass A, QUASAR Study Group. Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study. Gastroenterology. 2023 Dec; 165(6):1443-1457. PMID: 37659673.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    36. Dubinsky MC, Gardiner S, Hur P, Mundayat R, Rubin DT, Biedermann L, Vermeire S, Fellmann M, Panés J. Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open. Inflamm Bowel Dis. 2023 09 01; 29(9):1370-1379. PMID: 36242764; PMCID: PMC10472737.
      Citations:    Fields:    Translation:Humans
    37. Akiyama S, Cohen NA, Rubin DT, Kayal M, Dubinsky MC, Colombel JF. Treatment of Chronic Inflammatory Pouch Conditions With Tofacitinib: A Case Series From 2 Tertiary IBD Centers in the United States. Inflamm Bowel Dis. 2023 09 01; 29(9):1504-1507. PMID: 36745039; PMCID: PMC10472733.
      Citations: 2     Fields:    Translation:Humans
    38. Travis S, Potts Bleakman A, Dubinsky MC, Schreiber S, Panaccione R, Hibi T, Hunter Gibble T, Kayhan C, Atkinson C, Sapin C, Flynn EJ, Rubin DT. The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis. Inflamm Bowel Dis. 2023 Aug 21. PMID: 37603837.
      Citations: 2     Fields:    
    39. Rubin DT, Salese L, Cohen M, Kotze PG, Woolcott JC, Su C, Mundayat R, Paulissen J, Torres J, Long MD. Presence of risk factors associated with colectomy among patients with ulcerative colitis: a post hoc analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical program. Therap Adv Gastroenterol. 2023; 16:17562848231189122. PMID: 37560161; PMCID: PMC10408314.
      Citations:    
    40. Scott FI, Ehrlich O, Wood D, Viator C, Rains C, DiMartino L, McArdle J, Adams G, Barkoff L, Caudle J, Cheng J, Kinnucan J, Persley K, Sariego J, Heller C, Rubin DT, Shah S. Creation of an Inflammatory Bowel Disease Referral Pathway for Identifying Patients Who Would Benefit From Inflammatory Bowel Disease Specialist Consultation. Inflamm Bowel Dis. 2023 08 01; 29(8):1177-1190. PMID: 36271884; PMCID: PMC10393070.
      Citations:    Fields:    Translation:Humans
    41. Sood A, Singh A, Mahajan R, Midha V, Bernstein CN, Rubin DT. (Re)Appraising Remission in Ulcerative Colitis. Inflamm Bowel Dis. 2023 08 01; 29(8):1317-1326. PMID: 35917172.
      Citations:    Fields:    Translation:Humans
    42. Parigi TL, D'Amico F, Abreu MT, Dignass A, Dotan I, Magro F, Griffiths AM, Jairath V, Iacucci M, Mantzaris GJ, O'Morain C, Reinisch W, Sachar DB, Turner D, Yamamoto T, Rubin DT, Peyrin-Biroulet L, Ghosh S, Danese S. Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting. Lancet Gastroenterol Hepatol. 2023 09; 8(9):853-859. PMID: 37423233.
      Citations: 9     Fields:    Translation:Humans
    43. Runde J, Veseli I, Fogarty EC, Watson AR, Clayssen Q, Yosef M, Shaiber A, Verma R, Quince C, Gerasimidis K, Rubin DT, Eren AM. Transient Suppression of Bacterial Populations Associated with Gut Health is Critical in Success of Exclusive Enteral Nutrition for Children with Crohn's Disease. J Crohns Colitis. 2023 Jul 05; 17(7):1103-1113. PMID: 36934439.
      Citations:    Fields:    Translation:HumansCells
    44. Ahmad HA, Adsul S, Germinaro M, Neimark E, Wichary J, Bouhnik Y, Peyrin-Biroulet L, Uzzan M, Abreu M, Carlier H, Dubinsky M, Jairath V, Modesto I, Mortensen E, Narula N, Oortwijn A, Protic M, Rubin DT, Oh YS, Reinisch W. Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions. J Crohns Colitis. 2023 Jul 05; 17(7):1066-1078. PMID: 36738443.
      Citations: 2     Fields:    Translation:Humans
    45. Shaw DG, Aguirre-Gamboa R, Vieira MC, Gona S, DiNardi N, Wang A, Dumaine A, Gelderloos-Arends J, Earley ZM, Meckel KR, Ciszewski C, Castillo A, Monroe K, Torres J, Shah SC, Colombel JF, Itzkowitz S, Newberry R, Cohen RD, Rubin DT, Quince C, Cobey S, Jonkers IH, Weber CR, Pekow J, Wilson PC, Barreiro LB, Jabri B. Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis. Nat Med. 2023 Jun; 29(6):1520-1529. PMID: 37322120; PMCID: PMC10287559.
      Citations: 3     Fields:    Translation:Humans
    46. Bleakman AP, Dignass A, Redondo I, Gibble TH, Kayhan C, Dubinsky M, Panaccione R, Hibi T, Schreiber S, Rubin D, Travis S. Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions. Am J Gastroenterol. 2023 11 01; 118(11):1940-1953. PMID: 37436151; PMCID: PMC10617668.
      Citations:    Fields:    Translation:Humans
    47. Mak JWY, Sun Y, Limsrivilai J, Abdullah M, Kaibullayeva J, Balderramo D, Vergara BI, Paudel MS, Banerjee R, Hilmi I, Ali RAR, Wei SC, Ng KK, Altuwaijri M, Kelly P, Yamamoto-Furusho JK, Kotze PG, Ahuja V, Chong VH, Dao HV, Abbey Y, Ching JYL, Ho A, Chan AKW, Bernstein CN, Gearry RB, Abreu M, Rubin DT, Dotan I, Hracs L, Kaplan GG, Ng SC, GIVES-21 Consortium. Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21). BMC Med Res Methodol. 2023 05 25; 23(1):129. PMID: 37231405; PMCID: PMC10209572.
      Citations: 4     Fields:    Translation:Humans
    48. Yuan W, Marwaha JS, Rakowsky ST, Palmer NP, Kohane IS, Rubin DT, Brat GA, Feuerstein JD. Trends in Medical Management of Moderately to Severely Active Ulcerative Colitis: A Nationwide Retrospective Analysis. Inflamm Bowel Dis. 2023 05 02; 29(5):695-704. PMID: 35786768; PMCID: PMC10152283.
      Citations: 1     Fields:    Translation:Humans
    49. Watson AR, Veseli I, DeLongchamp JZ, Silva M, Trigodet F, Lolans K, Shaiber A, Fogarty E, Runde JM, Quince C, Yu MK, Morrison HG, Lee STM, Kao D, Rubin DT, Jabri B, Louie T, Eren AM, Füssel J, Söylev A. Metabolic independence drives gut microbial colonization and resilience in health and disease. Genome Biol. 2023 04 17; 24(1):78. PMID: 37069665; PMCID: PMC10108530.
      Citations: 8     Fields:    Translation:Humans
    50. Choi DK, Rubin DT, Puangampai A, Lach M. Role and Impact of a Clinical Pharmacy Team at an Inflammatory Bowel Disease Center. Crohns Colitis 360. 2023 Apr; 5(2):otad018. PMID: 37082614; PMCID: PMC10111283.
      Citations: 1     
    51. Zorzi F, Rubin DT, Cleveland NK, Monteleone G, Calabrese E. Ultrasonographic Transmural Healing in Crohn's Disease. Am J Gastroenterol. 2023 06 01; 118(6):961-969. PMID: 36988302.
      Citations: 1     Fields:    Translation:Humans
    52. Dolinger MT, Krugliak Cleveland N, Rubin DT, Dubinsky MC. Guide to Intestinal Ultrasound Credentialing, Documentation, and Billing for Gastroenterologists in the United States. Am J Gastroenterol. 2023 09 01; 118(9):1528-1531. PMID: 36940447.
      Citations: 2     Fields:    Translation:Humans
    53. Jairath V, Abreu MT, Rubin DT, Reinisch W, Danese S, Olivera PA, Lasa JS, Zubiaurre I, Magro F, Rahier JF, Rabaud C, Peyrin-Biroulet L. Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Crohns Colitis. 2023 Mar 18; 17(2):199-210. PMID: 36087107.
      Citations: 1     Fields:    Translation:Humans
    54. Friedberg S, Choi D, Hunold T, Choi NK, Garcia NM, Picker EA, Cohen NA, Cohen RD, Dalal SR, Pekow J, Sakuraba A, Krugliak Cleveland N, Rubin DT. Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World Experience. Clin Gastroenterol Hepatol. 2023 07; 21(7):1913-1923.e2. PMID: 36898598.
      Citations: 7     Fields:    Translation:Humans
    55. Cleveland NK, Picker EA, Dolinger MT, Rubin DT. The Arrival of Intestinal Ultrasound for Inflammatory Bowel Disease Care in the United States. Gastroenterol Hepatol (N Y). 2023 Mar; 19(3):147-154. PMID: 37706105; PMCID: PMC10496276.
      Citations:    
    56. Kassim G, Yzet C, Nair N, Debebe A, Rendon A, Traboulsi C, Rubin DT, Maroli A, Coppola E, Carvello MM, Ben David N, De Lucia F, Sacchi M, Danese S, Spinelli A, Hirdes MMC, Ten Hove J, Oldenburg B, Cholapranee A, Riter M, Lukin D, Scherl E, Eren E, Sultan KS, Axelrad J, Sachar DB, Colombel JF. Long-Term Outcomes of the Excluded Rectum in Crohn's Disease: A Multicenter International Study. Inflamm Bowel Dis. 2023 03 01; 29(3):417-422. PMID: 35522225; PMCID: PMC10210615.
      Citations:    Fields:    Translation:Humans
    57. Miyatani Y, Choi D, Du X, Hart J, Rubin DT. Medically Refractory Lymphocytic Colitis Successfully Treated With Upadacitinib. ACG Case Rep J. 2023 Feb; 10(2):e00979. PMID: 36788789; PMCID: PMC9916037.
      Citations: 1     
    58. Rubin DT. Transmural Healing in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2023 Feb; 19(2):101-103. PMID: 36866113; PMCID: PMC9972610.
      Citations:    
    59. Mikolajczyk AE, Cohen NA, Watson S, Ackerman M, Goeppinger SR, Hart J, Turner JR, Rubin DT. Assessment of the Degree of Variation of Histologic Inflammation in Ulcerative Colitis. Inflamm Bowel Dis. 2023 02 01; 29(2):222-227. PMID: 35436339; PMCID: PMC10686247.
      Citations: 1     Fields:    Translation:Humans
    60. Allocca M, Rubin DT, Kucharzik T. Intestinal Ultrasound in the Assessment and Management of Inflammatory Bowel Disease: Is It Ready for Standard Practice? Gastroenterology. 2023 05; 164(6):851-855. PMID: 36708790.
      Citations: 2     Fields:    Translation:Humans
    61. Garcia NM, Cohen NA, Rubin DT. Treat-to-target and sequencing therapies in Crohn's disease. United European Gastroenterol J. 2022 Dec 12. PMID: 36507876.
      Citations: 5     
    62. Zisman-Ilani Y, Thompson KD, Siegel LS, Mackenzie T, Crate DJ, Korzenik JR, Melmed GY, Kozuch P, Sands BE, Rubin DT, Regueiro MD, Cross R, Wolf DC, Hanson JS, Schwartz RM, Vrabie R, Kreines MD, Scherer T, Dubinsky MC, Siegel CA. Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial. Aliment Pharmacol Ther. 2023 01; 57(2):205-214. PMID: 36377259; PMCID: PMC9790033.
      Citations: 2     Fields:    Translation:Humans
    63. Rubin DT. Highlights in Ulcerative Colitis From the ACG Annual Scientific Meeting: Commentary. Gastroenterol Hepatol (N Y). 2022 Nov; 18(11 Suppl 3):13-16. PMID: 36866201; PMCID: PMC9972644.
      Citations:    
    64. Biedermann L, Dubinsky MC, Vermeire S, Fellmann M, Gardiner S, Hur P, Mundayat R, Panés J, Rubin DT. Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open. Inflamm Bowel Dis. 2022. View Publication.
    65. Cohen NA, Steinberg JM, Silfen A, Traboulsi C, Rodriguez TG, Singer JM, Patel S, Cohen RD, Dalal SR, Sakuraba A, Pekow J, Micic D, Rubin DT. Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes. Dig Dis Sci. 2023 04; 68(4):1464-1472. PMID: 36242686.
      Citations: 2     Fields:    Translation:Humans
    66. Tarabar D, El Jurdi K, Traboulsi C, Yvellez O, Milenkovic Z, Petrovic S, Subotic B, Gils A, Brocic T, Brcerevic I, Latinovic O, Jocic T, Rubin DT. A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab. Inflamm Bowel Dis. 2022 10 03; 28(10):1549-1554. PMID: 35078235.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    67. Cohen NA, Rubin DT. Endoscopic Management of Colitis-Associated Neoplasia. Gastrointest Endosc Clin N Am. 2022 Oct; 32(4):863-873. PMID: 36202521.
      Citations:    Fields:    Translation:Humans
    68. Runde J, Erondu A, Akiyama S, Traboulsi C, Rai V, Glick LR, Yi Y, Ollech JE, Cohen RD, Skowron KB, Hurst RD, Umanskiy K, Shogan BD, Hyman NH, Rubin MA, Dalal SR, Sakuraba A, Pekow J, Chang EB, Rubin DT. Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch-Anal Anastomosis in Pediatric Ulcerative Colitis. Inflamm Bowel Dis. 2022 09 01; 28(9):1386-1394. PMID: 35040964; PMCID: PMC9434476.
      Citations: 1     Fields:    Translation:Humans
    69. Christensen B, Prentice RE, Al-Ani AH, Zhang E, Bedell A, Rubin DT. Self-Reported Failure to Address Sexual Function in Patients With Inflammatory Bowel Disease by Gastroenterologists: Barriers and Areas for Improvement. Inflamm Bowel Dis. 2022 09 01; 28(9):1465-1468. PMID: 35286382.
      Citations: 1     Fields:    Translation:Humans
    70. Hanzel J, Jairath V, De Cruz P, Guizzetti L, Shackelton LM, Bossuyt P, Duijvestein M, Dulai PS, Hirten RP, Khanna R, Panes J, Regueiro M, Rubin DT, Singh S, Stidham RW, Sandborn WJ, Feagan BG, D'Haens GR, Ma C, Grossmann J, Peyrin-Biroulet L. Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn's Disease. Inflamm Bowel Dis. 2022 09 01; 28(9):1321-1331. PMID: 34791254.
      Citations: 2     Fields:    Translation:Humans
    71. Chen B, Zhong J, Li X, Pan F, Ding Y, Zhang Y, Chen H, Liu F, Zhang Z, Zhang L, Drozda R, Oliinyk O, Goh AH, Chen X, Sun X, Rubin DT, Sandborn WJ, Chen M. Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study. Gastroenterology. 2022 12; 163(6):1555-1568. PMID: 35963369.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    72. Choi DK, Rubin DT, Puangampai A, Cleveland N. Hypertensive Emergency After Initiating Ozanimod: A Case Report. Inflamm Bowel Dis. 2022 08 01; 28(8):e114-e115. PMID: 35212384.
      Citations: 1     Fields:    Translation:Humans
    73. Cohen NA, Dalal SR, Choi D, Rubin DT. Ozanimod Maintenance Therapy After Cyclosporine Induction in Acute Severe Ulcerative Colitis. ACG Case Rep J. 2022 Jul; 9(7):e00832. PMID: 35919406; PMCID: PMC9302285.
      Citations: 4     
    74. Buie MJ, Quan J, Windsor JW, Coward S, Hansen TM, King JA, Gearry RB, Ng SC, Mak JWY, Abreu MT, Rubin DT, Bernstein CN, Banerjee R, Yamamoto-Furusho JK, Panaccione R, Seow CH, Ma C, Underwood FE, Ahuja V, Panaccione N, Shaheen AA, Holroyd-Leduc J, Kaplan GG, Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) Research Group, Chong VH, Dutta U, Simadibrata M, Kaibullayeva J, Sun Y, Hilmi I, Raja Ali RA, Paudel MS, Altuwaijri M, Hartono JL, Wei SC, Limsrivilai J, El Ouali S, Dao VH, Kelly P, Hodges P, Miao Y, Li M, Kotze PG, Balderramo D, Juliao-Baños F, Vergara BI. Global Hospitalization Trends for Crohn's Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses. Clin Gastroenterol Hepatol. 2023 08; 21(9):2211-2221. PMID: 35863682.
      Citations: 20     Fields:    Translation:Humans
    75. Akiyama S, Dyer EC, Rubin DT. Diagnostic and Management Considerations for the IPAA With Crohn's Disease-Like Features. Dis Colon Rectum. 2022 Dec 01; 65(S1):S77-S84. PMID: 35867686.
      Citations: 1     Fields:    Translation:Humans
    76. Kiran RP, Kochhar GS, Kariv R, Rex DK, Sugita A, Rubin DT, Navaneethan U, Hull TL, Ko HM, Liu X, Kachnic LA, Strong S, Iacucci M, Bemelman W, Fleshner P, Safyan RA, Faiz O, Lo S, Ashburn JH, Spinelli A, Bernstein CN, Kane SV, Cross RK, Schairer J, McCormick JT, Farraye FA, Chang S, Scherl EJ, Schwartz DA, Bruining DH, Philpott J, Bentley-Hibbert S, El-Hachem S, Sandborn WJ, Silverberg MS, Pardi DS, Church JM, Shen B, Kotze PG, D'Hoore A, Tarabar D. Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2022 09; 7(9):871-893. PMID: 35798022.
      Citations: 1     Fields:    Translation:Humans
    77. Cohen NA, Zafer M, Setia N, Anderson MJ, Sakuraba A, Dalal S, Pekow J, Cohen RD, Rubin DT, Micic D. Serum Cytomegalovirus Polymerase Chain Reaction Test Is a Valuable Negative Predictor of Infection in Acute Severe Ulcerative Colitis. Dig Dis Sci. 2023 03; 68(3):897-901. PMID: 35781654.
      Citations:    Fields:    Translation:HumansCells
    78. CORE-IBD Collaborators, Ma C, Hanzel J, Panaccione R, Sandborn WJ, D'Haens GR, Ahuja V, Bernstein CN, Bossuyt P, Bressler B, Bryant RV, Cohen B, Colombel JF, Danese S, Dignass A, Dubinsky MC, Fleshner PR, Gearry RB, Hanauer SB, Hart A, Lakatos PL, Leong RW, Ran Z, Regueiro M, Singh S, Spinelli A, Steinhart AH, Travis SP, van der Woude CJ, Yacyshyn B, Yamamoto T, Bemelman WA, Lightner AL, Rubin DT, Scherl EJ, Siegel CA, Silverberg MS, Vermeire S, Parker CE, McFarlane SC, Guizzetti L, Smith MI, Vande Casteele N, Feagan BG, Jairath V, Atreya R, Kotze PG, Kucharzik T, Magro F, Panés J, Peyrin-Biroulet L, Allez M, Louis E. CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease. Gastroenterology. 2022 10; 163(4):950-964. PMID: 35788348.
      Citations: 10     Fields:    Translation:Humans
    79. Rubin DT. Highlights in Ulcerative Colitis From Digestive Disease Week 2022: Commentary. Gastroenterol Hepatol (N Y). 2022 Jul; 18(7 Suppl 2):12-16. PMID: 36756652; PMCID: PMC9671064.
      Citations: 1     
    80. Friedberg S, Hanan I, Hyman N, Rubio G, Sharma A, Rubin DT. Ileal Desmoid Tumor in Ileal Crohn's: Coincidence or Connection? Dig Dis Sci. 2023 03; 68(3):1071-1073. PMID: 35713837.
      Citations:    Fields:    Translation:Humans
    81. Traboulsi C, Ayoub F, Silfen A, Rodriguez TG, Rubin DT. Upadacitinib Is Safe and Effective for Crohn's Disease: Real-World Data from a Tertiary Center. Dig Dis Sci. 2023 02; 68(2):385-388. PMID: 35695972.
      Citations: 4     Fields:    Translation:Humans
    82. D'Haens G, Panaccione R, Baert F, Bossuyt P, Colombel JF, Danese S, Dubinsky M, Feagan BG, Hisamatsu T, Lim A, Lindsay JO, Loftus EV, Peyrin-Biroulet L, Ran Z, Rubin DT, Sandborn WJ, Schreiber S, Neimark E, Song A, Kligys K, Pang Y, Pivorunas V, Berg S, Duan WR, Huang B, Kalabic J, Liao X, Robinson A, Wallace K, Ferrante M, Panés J. Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials. Lancet. 2022 05 28; 399(10340):2015-2030. PMID: 35644154.
      Citations: 56     Fields:    Translation:Humans
    83. Ferrante M, Panaccione R, Baert F, Bossuyt P, Colombel JF, Danese S, Dubinsky M, Feagan BG, Hisamatsu T, Lim A, Lindsay JO, Loftus EV, Peyrin-Biroulet L, Ran Z, Rubin DT, Sandborn WJ, Schreiber S, Neimark E, Song A, Kligys K, Pang Y, Pivorunas V, Berg S, Duan WR, Huang B, Kalabic J, Liao X, Robinson A, Wallace K, D'Haens G, Panés J. Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial. Lancet. 2022 05 28; 399(10340):2031-2046. PMID: 35644155.
      Citations: 42     Fields:    Translation:HumansCTClinical Trials
    84. McDonald BD, Dyer EC, Rubin DT. IL-23 Monoclonal Antibodies for IBD: So Many, So Different? J Crohns Colitis. 2022 May 11; 16(Supplement_2):ii42-ii53. PMID: 35553664; PMCID: PMC9097671.
      Citations: 6     Fields:    Translation:Humans
    85. Parigi TL, D'Amico F, Abreu MT, Rubin DT, Dignass A, Dotan I, Jairath V, Peyrin-Biroulet L, Ghosh S, Danese S, Magro F. Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey. Lancet Gastroenterol Hepatol. 2022 05; 7(5):390-391. PMID: 35397241.
      Citations: 3     Fields:    Translation:Humans
    86. Choden T, Cohen NA, Rubin DT. Sphingosine-1 Phosphate Receptor Modulators: The Next Wave of Oral Therapies in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2022 May; 18(5):265-271. PMID: 36397756; PMCID: PMC9666818.
      Citations: 4     
    87. Ananthakrishnan AN, Kaplan GG, Bernstein CN, Burke KE, Lochhead PJ, Sasson AN, Agrawal M, Tiong JHT, Steinberg J, Kruis W, Ahuja V, Ng SC, Rubin DT, Colombel JF, Gearry R, International Organization for Study of Inflammatory Bowel Diseases, Steinwurz F. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus. Lancet Gastroenterol Hepatol. 2022 07; 7(7):666-678. PMID: 35487235.
      Citations: 16     Fields:    Translation:Humans
    88. Friedberg S, Rubin DT. Intestinal Cancer and Dysplasia in Crohn's Disease. Gastroenterol Clin North Am. 2022 06; 51(2):369-379. PMID: 35595420.
      Citations: 1     Fields:    Translation:Humans
    89. Cohen NA, Choi D, Choden T, Cleveland NK, Cohen RD, Rubin DT. Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary Center. Clin Gastroenterol Hepatol. 2023 08; 21(9):2407-2409.e2. PMID: 35381385; PMCID: PMC11009929.
      Citations: 2     Fields:    Translation:Humans
    90. Rubin DT. Highlights in Ulcerative Colitis From the 17th Congress of the European Crohn's and Colitis Organisation: Commentary. Gastroenterol Hepatol (N Y). 2022 Apr; 18(4 Suppl 1):13-16. PMID: 35610991; PMCID: PMC9122072.
      Citations:    
    91. Shaffer SR, Erondu AI, Traboulsi C, Rai V, Krugliak Cleveland N, Israel A, Christensen B, Rubin DT. Achieving Histologic Normalization in Ulcerative Colitis Is Associated With a Reduced Risk of Subsequent Dysplasia. Inflamm Bowel Dis. 2022 03 30; 28(4):553-559. PMID: 34037230; PMCID: PMC9122749.
      Citations: 3     Fields:    Translation:Humans
    92. Choi DK, Puangampai A, Rubin DT. Prior Authorization for Ustekinumab Dose Escalation Negatively Affects Outcomes in Patients With Inflammatory Bowel Disease. Ann Pharmacother. 2022 Mar 18; 10600280221080986. PMID: 35300521.
      Citations: 2     Fields:    
    93. Anyane-Yeboa A, Quezada S, Rubin DT, Balzora S. The Impact of the Social Determinants of Health on Disparities in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2022 11; 20(11):2427-2434. PMID: 35307597.
      Citations: 4     Fields:    Translation:Humans
    94. Akiyama S, Ollech JE, Traboulsi C, Rai V, Glick LR, Yi Y, Runde J, Olivas AD, Weber CR, Cohen RD, Olortegui KBS, Hurst RD, Umanskiy K, Shogan BD, Rubin MA, Dalal SR, Sakuraba A, Pekow J, Chang EB, Hart J, Hyman NH, Rubin DT. Histopathology of Colectomy Specimens Predicts Endoscopic Pouch Phenotype in Patients with Ulcerative Colitis. Dig Dis Sci. 2022 08; 67(8):4020-4031. PMID: 35288827; PMCID: PMC10966959.
      Citations: 1     Fields:    Translation:Humans
    95. Click B, Barnes EL, Cohen BL, Sands BE, Hanson JS, Rubin DT, Dubinsky MC, Regueiro M, Gazis D, Crawford JM, Long MD. Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD. BMC Gastroenterol. 2022 Feb 19; 22(1):71. PMID: 35183108; PMCID: PMC8858477.
      Citations: 1     Fields:    Translation:Humans
    96. Abreu MT, Siegel CA, Panaccione R, Sands BE, Dignass A, Turner D, Dotan I, Hart AL, Ahuja V, Ananthakrishnan AN, Ghosh S, Griffiths AM, Kaser A, Koutroubakis IE, Lakatos PL, Levine A, Lewis JD, Mantzaris GJ, O'Morain C, Ran Z, Reinisch W, Rogler G, Sachar DB, Silverberg MS, Sood A, Spinelli A, Schreiber S, Rubin DT, Sandborn WJ, Danese S, Caron B, Allez M, Halfvarson J, Kotze PG, Magro F, Siegmund B, Steinwurz F, Tysk C, Yamamoto-Furusho JK, Peyrin-Biroulet L. IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus. Clin Gastroenterol Hepatol. 2022 11; 20(11):2619-2627.e1. PMID: 35189386.
      Citations:    Fields:    Translation:Humans
    97. Quera R, Rubin DT, Núñez F P. Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forget. World J Gastrointest Endosc. 2022 Feb 16; 14(2):85-95. PMID: 35316980; PMCID: PMC8908328.
      Citations: 3     
    98. Hart AL, Rubin DT. Entering the Era of Disease Modification in Inflammatory Bowel Disease. Gastroenterology. 2022 04; 162(5):1367-1369. PMID: 35202593.
      Citations: 2     Fields:    Translation:Humans
    99. Ayoub F, Odenwald M, Micic D, Dalal SR, Pekow J, Cohen RD, Rubin DT, Sakuraba A. Vedolizumab for perianal fistulizing Crohn's disease: systematic review and meta-analysis. Intest Res. 2022 Apr; 20(2):240-250. PMID: 35124951; PMCID: PMC9081994.
      Citations: 7     
    100. Sandborn WJ, D'Haens GR, Reinisch W, Chan D, Gonzalez S, Weisel K, Germinaro M, Frustaci ME, Yang Z, Adedokun OJ, Han C, Panaccione R, Hisamatsu T, Danese S, Rubin DT, Sands BE, Afzali A, Andrews JM, Feagan BG, GALAXI-1 Investigators, Panés J. Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study. Gastroenterology. 2022 05; 162(6):1650-1664.e8. PMID: 35134323.
      Citations: 34     Fields:    Translation:HumansCTClinical Trials
    101. Krugliak Cleveland N, Rubin DT, Torres J. What Does Disease Progression Look Like in Ulcerative Colitis, and How Might It Be Prevented? Gastroenterology. 2022 04; 162(5):1396-1408. PMID: 35101421.
      Citations: 20     Fields:    Translation:Humans
    102. Guillo L, Abreu M, Panaccione R, Sandborn WJ, Gensler L, Moghaddam B, Ahuja V, Ali SA, Ananthakrishnan AN, Bhattacharya A, Dubinsky M, Griffiths A, Hart A, Korelitz B, Koutroubakis IE, Lakatos PL, Lindsay JO, Mantzaris GJ, Ng SC, O'Morain C, Parigi T, Ran Z, Rogler G, Rubin DT, Sachar DB, Steinwurz F, Vavricka S, Verstraete SG, Haemel AK, Dignass A, Sands BE, Danese S, Azevedo VF, Allez M, Kotze PG, Magro F, Panés J, Siegmund B, Tysk C, Brezin AP, Peyrin-Biroulet L. Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases. Lancet Gastroenterol Hepatol. 2022 03; 7(3):254-261. PMID: 35051383.
      Citations: 8     Fields:    Translation:Humans
    103. Zafer M, Zhang H, Dwadasi S, Goens D, Paknikar R, Dalal S, Cohen RD, Pekow J, Rubin DT, Sakuraba A, Micic D. A Clinical Predictive Model for One-year Colectomy in Adults Hospitalized for Severe Ulcerative Colitis. Crohns Colitis 360. 2022 Jan; 4(1):otab082. PMID: 36777555; PMCID: PMC9802419.
      Citations:    
    104. Rubin DT, Peyrin-Biroulet L, Reinisch W, Tole S, Sullivan L, Park KT, Regueiro M. Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis. Crohns Colitis 360. 2021 Oct; 3(4):otab079. PMID: 36777264; PMCID: PMC9802428.
      Citations: 1     
    105. Rubin D, Panaccione R, Potts Bleakman A, Kayhan C, Atkinson C, Hunter Gibble T, Ellis H, Healey K, Shan M, Hibi T. P028 Communicating Needs and Features of IBD Experiences (CONFIDE) Survey: Patient and Healthcare Professional Perspectives on Experience of Ulcerative Colitis Symptoms. Am J Gastroenterol. 2021 Dec 01; 116(Suppl 1):S7. PMID: 37461947.
      Citations: 1     Fields:    
    106. Rubin D, Panaccione R, Potts Bleakman A, Kayhan C, Atkinson C, Hunter Gibble T, Ellis H, Healey K, Shan M, Hibi T. P028 Communicating Needs and Features of IBD Experiences (CONFIDE) Survey: Patient and Healthcare Professional Perspectives on Experience of Ulcerative Colitis Symptoms. Am J Gastroenterol. 2021 Dec 01; 116(Suppl 1):S7. PMID: 35006156.
      Citations:    
    107. Melmed GY, Oliver B, Hou JK, Lum D, Singh S, Crate D, Almario C, Bray H, Bresee C, Gerich M, Gerner D, Heagy E, Holthoff M, Hudesman D, McCutcheon Adams K, Mattar MC, Metwally M, Nelson E, Ostrov A, Rubin DT, Scott F, Samir S, van Deen W, Younes Z, Oberai R, Weaver A, Siegel CA, IBD Qorus. Quality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2021 12 01; 116(12):2410-2418. PMID: 34797226.
      Citations: 4     Fields:    Translation:Humans
    108. Akiyama S, Lin A, Traboulsi C, Rubin DT. Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib. ACG Case Rep J. 2021 Nov; 8(11):e00690. PMID: 34840997; PMCID: PMC8613360.
      Citations: 2     
    109. Rubin DT, Dotan I, DuVall A, Radford-Smith G, Higgins PDR, Mishkin DS, Arrisi P, Scalori A, Oh YS, Tole S, Chai A, Chamberlain-James K, Lacey S, McBride J, HIBISCUS Study Group, Bouhnik Y, Panés J. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. Lancet Gastroenterol Hepatol. 2022 01; 7(1):17-27. PMID: 34798036.
      Citations: 20     Fields:    Translation:HumansCTClinical Trials
    110. Curtis JR, Zhou X, Rubin DT, Reinisch W, Yazdany J, Robinson PC, Chen Y, Benda B, Madsen A, Geier J. Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based Study. J Rheumatol. 2022 03; 49(3):320-329. PMID: 34782447.
      Citations: 9     Fields:    Translation:HumansCells
    111. Rubin DT, Sninsky C, Hart A, Bressler B, Armuzzi A, Afzali A, Siegmund B, Sans M, Bouhnik Y. International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey. Inflamm Bowel Dis. 2021 11 15; 27(12):1942-1953. PMID: 33512475; PMCID: PMC8637792.
      Citations: 17     Fields:    Translation:Humans
    112. Shen B, Kochhar GS, Rubin DT, Kane SV, Navaneethan U, Bernstein CN, Cross RK, Sugita A, Schairer J, Kiran RP, Fleshner P, McCormick JT, Shah SA, Farraye FA, Kariv R, Liu X, Rosh J, Chang S, Scherl E, Schwartz DA, Bruining DH, Philpott J, Abraham B, Segal J, Sedano R, Kayal M, Bentley-Hibbert S, El-Hachem S, Sehgal P, Picoraro JA, Sandborn WJ, Silverberg MS, Pardi DS, D'Hoore A, Kotze PG, Tarabar D, Vermeire S. Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2022 01; 7(1):69-95. PMID: 34774224.
      Citations: 15     Fields:    Translation:HumansPHPublic Health
    113. Dwadasi S, Zafer M, Goens D, Paknikar R, Dalal S, Cohen RD, Pekow J, Rubin DT, Sakuraba A, Micic D. Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis. Inflamm Bowel Dis. 2021 10 18; 27(10):1620-1625. PMID: 33319248; PMCID: PMC8682443.
      Citations: 3     Fields:    Translation:Humans
    114. Rubin DT, Modesto I, Danese S, Ng SC, Kwok KK, Koram N, Jones TV, Vermeire S. Worldwide post-marketing safety surveillance experience with tofacitinib in ulcerative colitis. Aliment Pharmacol Ther. 2022 02; 55(3):302-310. PMID: 34626429; PMCID: PMC9293472.
      Citations: 14     Fields:    Translation:Humans
    115. Bressler B, Yarur A, Silverberg MS, Bassel M, Bellaguarda E, Fourment C, Gatopoulou A, Karatzas P, Kopylov U, Michalopoulos G, Michopoulos S, Navaneethan U, Rubin DT, Siffledeen J, Singh A, Soufleris K, Stein D, Demuth D, Mantzaris GJ. Vedolizumab and Anti-Tumour Necrosis Factor a Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study. J Crohns Colitis. 2021 Oct 07; 15(10):1694-1706. PMID: 33786600; PMCID: PMC8495488.
      Citations: 23     Fields:    Translation:Humans
    116. Ayoub F, Ouni A, Rubin DT, Case R, Ladna M, Shah H. Dissemination of Gastroenterology and Hepatology Research on Social Media Platforms Is Associated With Increased Citation Count. Am J Gastroenterol. 2021 10 01; 116(10):2137-2139. PMID: 33767107.
      Citations: 3     Fields:    Translation:Humans
    117. Krugliak Cleveland N, Rai V, El Jurdi K, Rao SS, Giurcanu MC, Rubin DT. Ulcerative Colitis Patients Have Reduced Rectal Compliance Compared With Non-Inflammatory Bowel Disease Controls. Gastroenterology. 2022 01; 162(1):331-333.e1. PMID: 34597674; PMCID: PMC8678316.
      Citations: 8     Fields:    Translation:Humans
    118. Cohen NA, Silfen A, Rubin DT. Inclusion of Under-represented Racial and Ethnic Minorities in Randomized Clinical Trials for Inflammatory Bowel Disease. Gastroenterology. 2022 01; 162(1):17-21. PMID: 34562464; PMCID: PMC8678318.
      Citations: 9     Fields:    Translation:Humans
    119. Akiyama S, Rodriguez TG, Rubin DT. Stratifying Risks of Ileal Pouch Outcomes. Clin Gastroenterol Hepatol. 2022 07; 20(7):1620-1621. PMID: 34481959.
      Citations: 1     Fields:    Translation:Humans
    120. Shaffer SR, Rubin DT. Response to Tetangco and Hanauer. Am J Gastroenterol. 2021 09 01; 116(9):1959-1960. PMID: 34101668.
      Citations:    Fields:    
    121. Aby ES, Kriss M, Rubin DT, Pillai A. How to Navigate National Societal Organizations for Leadership Development and Academic Promotion: A Guide for Trainees and Young Faculty. Gastroenterology. 2021 11; 161(5):1361-1365. PMID: 34464630.
      Citations: 1     Fields:    Translation:Humans
    122. Regnault V, Al Awadhi S, Bossuyt P, Gearry RB, Ghosh S, Kobayashi T, Lacolley P, Ng SC, Papa A, Raine T, Rubin DT, Danese S, Olivera PA, Zuily S, Kotze PG, Louis E, Magro F, Teixeira FV, Peyrin-Biroulet L. International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021 12; 18(12):857-873. PMID: 34453143; PMCID: PMC8395387.
      Citations: 27     Fields:    Translation:Humans
    123. Shen B, Kochhar GS, Kariv R, Liu X, Navaneethan U, Rubin DT, Cross RK, Sugita A, Schairer J, Farraye FA, Kiran RP, Fleshner P, Rosh J, Shah SA, Chang S, Scherl E, Pardi DS, Schwartz DA, Bruining DH, Kane SV, Philpott J, Abraham B, Segal J, Sedano R, Kayal M, Bentley-Hibbert S, El-Hachem S, Sehgal P, McCormick JT, Picoraro JA, Silverberg MS, Bernstein CN, Sandborn WJ, D'Hoore A, Kotze PG, Tarabar D, Vermeire S. Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2021 10; 6(10):826-849. PMID: 34416186.
      Citations: 22     Fields:    Translation:Humans
    124. Buisson A, Cannon L, Umanskiy K, Hurst RD, Hyman NH, Sakuraba A, Pekow J, Dalal S, Cohen RD, Pereira B, Rubin DT. Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn's disease. Intest Res. 2022 Jul; 20(3):303-312. PMID: 34333909; PMCID: PMC9344250.
      Citations: 2     
    125. Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. Gastroenterology. 2021 10; 161(4):1118-1132. PMID: 34358489; PMCID: PMC8564770.
      Citations: 127     Fields:    Translation:Humans
    126. Rai V, Traboulsi C, Silfen A, Ackerman MT, Erondu AI, Karpin JE, Gulotta G, Rubin DT. Identification of Risk Factors for Coexisting Sinusitis and Inflammatory Bowel Disease. Crohns Colitis 360. 2021 Jul; 3(3). PMID: 35531367; PMCID: PMC9075692.
      Citations: 1     
    127. Cleveland NK, Rubin DT. CANCER PREVENTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Pract Gastroenterol. 2021 Aug; 45(8):12-28. PMID: 34707325; PMCID: PMC8547793.
      Citations: 2     
    128. Rubin DT, Griffith J, Zhang Q, Hepp Z, Keshishian A. The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor Therapies. Inflamm Bowel Dis. 2021 07 27; 27(8):1201-1209. PMID: 33107564; PMCID: PMC8600026.
      Citations: 3     Fields:    Translation:Humans
    129. Normatov I, Fluxa D, Wang JD, Ollech JE, Gulotta GE, Patel S, Quintero MA, De la Torre B, Solis N, Damas OM, Deshpande AR, Kerman DH, Abreu MT, Rubin DT. Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab Reintroduction. Crohns Colitis 360. 2021 Jul; 3(3):otab048. PMID: 36776674; PMCID: PMC9802083.
      Citations:    
    130. Maltz RM, McNicol M, Wingate L, Buchanan S, Sandell A, Kim SC, Rubin DT. There Is No Substitute for Effective Education About Biosimilars. Crohns Colitis 360. 2021 Oct; 3(4):otab047. PMID: 36777278; PMCID: PMC9802262.
      Citations: 1     
    131. Su C, Lawendy N, Kobayashi T, Sandborn WJ, Rubin DT, Modesto I, Gardiner S, Kulisek N, Zhang H, Wang W, Vermeire S, Panés J. Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomised RIVETING Trial. J Crohns Colitis. 2021 Jul 05; 15(7):1130-1141. PMID: 33290538; PMCID: PMC8256630.
      Citations: 21     Fields:    Translation:Humans
    132. Cohen NA, Rubin DT. New targets in inflammatory bowel disease therapy: 2021. Curr Opin Gastroenterol. 2021 07 01; 37(4):357-363. PMID: 34059604; PMCID: PMC8544288.
      Citations: 14     Fields:    Translation:Humans
    133. El Ouali S, Rubin DT, Cohen BL, Regueiro MD, Rieder F. Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic. Curr Opin Gastroenterol. 2021 07 01; 37(4):313-319. PMID: 33859104; PMCID: PMC8285035.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    134. Dubinsky MC, Dotan I, Rubin DT, Bernauer M, Patel D, Cheung R, Modesto I, Latymer M, Keefer L. Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review. Expert Rev Gastroenterol Hepatol. 2021 Sep; 15(9):985-997. PMID: 34130572.
      Citations: 19     Fields:    Translation:Humans
    135. Rubin DT, Hart A, Panaccione R, Suvanto U, Deuring JJ, Woolcott J, Cappelleri JC, Steinberg K, Wingate L, Schreiber S, Armuzzi A. Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians. Inflamm Bowel Dis. 2021 06 15; 27(7):1096-1106. PMID: 33057598; PMCID: PMC8214018.
      Citations: 15     Fields:    Translation:Humans
    136. Buisson A, Mak WY, Andersen MJ, Lei D, Pekow J, Cohen RD, Kahn SA, Rubin DT, Pereira B. Fecal Calprotectin Is Highly Effective to Detect Endoscopic Ulcerations in Crohn's Disease Regardless of Disease Location. Inflamm Bowel Dis. 2021 06 15; 27(7):1008-1016. PMID: 33107563; PMCID: PMC8600021.
      Citations: 10     Fields:    Translation:Humans
    137. Barnes EL, Hanson JS, Regueiro MD, Saha S, Sands BE, Rubin DT, Dubinsky MC, Siegel CA, Gazis DR, Crawford JM, Long MD. Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD. J Clin Gastroenterol. 2022 07 01; 56(6):529-535. PMID: 34115661.
      Citations: 1     Fields:    Translation:Humans
    138. Khanna S, Tande A, Rubin DT, Khoruts A, Kahn SA, Pardi DS. Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic: Experience and Recommendations. Mayo Clin Proc. 2021 06; 96(6):1418-1425. PMID: 34088413; PMCID: PMC8169126.
      Citations: 11     Fields:    Translation:HumansCells
    139. Krugliak Cleveland N, Quera R, Rubin DT, Núñez F P. Evolving role of endoscopy in inflammatory bowel disease: Going beyond diagnosis. World J Gastroenterol. 2021 May 28; 27(20):2521-2530. PMID: 34092973; PMCID: PMC8160621.
      Citations: 4     Fields:    Translation:Humans
    140. Akiyama S, Yamada A, Ollech JE, Komaki Y, Komaki F, Pekow J, Dalal SR, Cohen RD, Rubin DT, Sakuraba A. Predictability of simple endoscopic score for Crohn's disease for postoperative outcomes in Crohn's disease. J Gastroenterol Hepatol. 2021 Oct; 36(10):2785-2793. PMID: 33973282.
      Citations: 3     Fields:    Translation:Humans
    141. Lin A, Roth H, Anyane-Yeboa A, Rubin DT, Paul S. Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2021 05 17; 27(6):947-955. PMID: 32780094; PMCID: PMC8600033.
      Citations: 24     Fields:    Translation:Humans
    142. Bernstein CN, Ng SC, Banerjee R, Steinwurz F, Shen B, Hamid S, Sood A, Yamamoto-Furusho JK, Griffiths A, Benchimol EI, Travis S, Rubin DT, Kaplan GG, Armstrong D, Gearry R, IBD-Emerging Nations Consortium and the WGO IBD Task Force on COVID-19, Carbonnel F, Lopes S. Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey. Inflamm Bowel Dis. 2021 05 17; 27(6):836-847. PMID: 32793973; PMCID: PMC7454666.
      Citations: 15     Fields:    Translation:HumansCells
    143. Rubin DT, Reinisch W, Mundayat R, Maller E, Lawendy N, Modesto I, Lichtenstein GR, Greuter T, Kotze PG, Pinheiro M, Fellmann M, Vavricka SR. Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis. Therap Adv Gastroenterol. 2021; 14:17562848211005708. PMID: 34035832; PMCID: PMC8132089.
      Citations: 6     
    144. Shaffer SR, Traboulsi C, Krugliak Cleveland N, Rubin DT. Combining Cyclosporine With Ustekinumab in Acute Severe Ulcerative Colitis. ACG Case Rep J. 2021 May; 8(5):e00604. PMID: 34007860; PMCID: PMC8126549.
      Citations: 11     
    145. Click B, Barnes EL, Cohen BL, Sands BE, Hanson JS, Regueiro M, Rubin DT, Dubinsky MC, Gazis DR, Dalfonso L, Hildebrand JS, Crawford JM, Long MD. Methodology and Initial Results From a Real-World Observational Cohort of Patients With Inflammatory Bowel Disease: TARGET-IBD. Crohns Colitis 360. 2021 Jul; 3(3):otab023. PMID: 36776639; PMCID: PMC9802086.
      Citations: 1     
    146. D'Amico F, Rubin DT, Kobayashi T, Bossuyt P, Pouillon L, Ghosh S, Danese S, Kotze PG, Magro F, Siegmund B, Olivera PA, Louis E, Domènech E, Peyrin-Biroulet L. International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases. United European Gastroenterol J. 2021 05; 9(4):451-460. PMID: 33961734; PMCID: PMC8259254.
      Citations: 12     Translation:Humans
    147. Rubin DT, Pariente B, Laharie D, Roblin X, Peyrin-Biroulet L, USTEK Post-Op study group, Buisson A, Nancey S, Manlay L, Hebuterne X, Fumery M, Bommelaer G, Pereira B, Vuitton L. Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease. United European Gastroenterol J. 2021 06; 9(5):552-560. PMID: 33951350; PMCID: PMC8259431.
      Citations: 10     Translation:HumansPHPublic Health
    148. Melmed G, Rubin DT, McGovern D. Reply. Gastroenterology. 2021 07; 161(1):369-370. PMID: 33831380; PMCID: PMC8162783.
      Citations:    Fields:    
    149. Rubin GA, Desai AD, Chai Z, Wang A, Chen Q, Wang AS, Kemal C, Baksh H, Biviano A, Dizon JM, Yarmohammadi H, Ehlert F, Saluja D, Rubin DA, Morrow JP, Avula UMR, Berman JP, Kushnir A, Abrams MP, Hennessey JA, Elias P, Poterucha TJ, Uriel N, Kubin CJ, LaSota E, Zucker J, Sobieszczyk ME, Schwartz A, Garan H, Waase MP, Wan EY. Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic. JAMA Netw Open. 2021 04 01; 4(4):e216842. PMID: 33890991; PMCID: PMC8065381.
      Citations: 19     Fields:    Translation:HumansCells
    150. Yi Y, Sossenheimer PH, Erondu AI, Skowron KB, Rai V, Singer JM, El Jurdi K, Hyman NH, Rubin DT. Using Wearable Biosensors to Predict Length of Stay for Patients with IBD After Bowel Surgery. Dig Dis Sci. 2022 03; 67(3):844-853. PMID: 33761092; PMCID: PMC8564769.
      Citations: 4     Fields:    Translation:Humans
    151. Sidebottom AM, Rodriguez TG, Karpin JE, Rubin DT. Clinical and Translational Considerations for Understanding Depression and Anxiety in Patients with Inflammatory Bowel Disease. Gastroenterol Res Pract. 2021; 2021:6689443. PMID: 33747075; PMCID: PMC7960036.
      Citations: 4     
    152. Turner D, Ricciuto A, Lewis A, D'Amico F, Dhaliwal J, Griffiths AM, Sandborn WJ, Sands BE, Reinisch W, Bemelman W, Danese S, Rubin D, Colombel JF, Dotan I, Abreu MT, Dignass A, International Organization for the Study of IBD, Bettenworth D, Schölmerich J, Mary JY, Peyrin-Biroulet L. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021 04; 160(5):1570-1583. PMID: 33359090.
      Citations: 472     Fields:    Translation:Humans
    153. Yamada A, Komaki Y, Komaki F, Haider H, Micic D, Pekow J, Dalal S, Cohen RD, Cannon L, Umanskiy K, Smith R, Shogan BD, Hurst R, Hyman N, Rubin DT, Sakuraba A. The Correlation between Vitamin D Levels and the Risk of Postoperative Recurrence in Crohn's Disease. Digestion. 2021; 102(5):767-775. PMID: 33556932.
      Citations: 7     Fields:    Translation:Humans
    154. Cohen RD, Feuerstein JD, Rubin DT. Reply. Gastroenterology. 2021 06; 160(7):2627. PMID: 33561439; PMCID: PMC7867470.
      Citations:    Fields:    
    155. Akiyama S, Ollech JE, Rai V, Glick LR, Yi Y, Traboulsi C, Runde J, Cohen RD, Skowron KB, Hurst RD, Umanskiy K, Shogan BD, Hyman NH, Rubin MA, Dalal SR, Sakuraba A, Pekow J, Chang EB, Rubin DT. Endoscopic Phenotype of the J Pouch in Patients With Inflammatory Bowel Disease: A New Classification for Pouch Outcomes. Clin Gastroenterol Hepatol. 2022 02; 20(2):293-302.e9. PMID: 33549868; PMCID: PMC8339185.
      Citations: 7     Fields:    Translation:Humans
    156. Gearry RB, McCombie AM, Vatn M, Rubin DT, Steinwurz F, Loftus EV, Kruis W, Tysk C, Colombel JF, Ng SC, Van Assche G, Bernstein CN. What Are the Most Challenging Aspects of Inflammatory Bowel Disease? An International Survey of Gastroenterologists Comparing Developed and Developing Countries. Inflamm Intest Dis. 2021 May; 6(2):78-86. PMID: 34124179; PMCID: PMC8160566.
      Citations: 3     
    157. Hong SJ, Krugliak Cleveland N, Akiyama S, Zullow S, Yi Y, Shaffer SR, Malter LB, Axelrad JE, Chang S, Hudesman DP, Rubin DT. Real-World Effectiveness and Safety of Ustekinumab for Ulcerative Colitis From 2 Tertiary IBD Centers in the United States. Crohns Colitis 360. 2021 Jan; 3(1):otab002. PMID: 36777067; PMCID: PMC9802405.
      Citations: 5     
    158. Rubin DT, Traboulsi C, Rai V. A Practical Clinical Approach to the Management of High-Risk Ulcerative Colitis. Gastroenterol Hepatol (N Y). 2021 Feb; 17(2):59-66. PMID: 34035764; PMCID: PMC8132723.
      Citations: 2     
    159. Rao VL, Aronsohn A, Rubin DT, Siegler M. How to Integrate a Medical Ethics Curriculum into Gastroenterology Fellowships. Gastroenterology. 2021 03; 160(4):1003-1006. PMID: 33497657.
      Citations:    Fields:    Translation:Humans
    160. Siegel CA, Melmed GY, McGovern DP, Rai V, Krammer F, Rubin DT, Abreu MT, Dubinsky MC, International Organization for the Study of Inflammatory Bowel Disease (IOIBD), International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting. Gut. 2021 Apr; 70(4):635-640. PMID: 33472895; PMCID: PMC7818789.
      Citations: 89     Fields:    Translation:HumansCellsPHPublic Health
    161. Feld LD, Mergener K, Rubin DT, Rao VL. Management of code status in the periendoscopic period: a national survey of current practices and beliefs of U.S. gastroenterologists. Gastrointest Endosc. 2021 07; 94(1):172-177.e2. PMID: 33476610.
      Citations:    Fields:    Translation:Humans
    162. Yvellez OV, Rai V, Sossenheimer PH, Hart J, Turner JR, Weber C, El Jurdi K, Rubin DT. Cumulative Histologic Inflammation Predicts Colorectal Neoplasia in Ulcerative Colitis: A Validation Study. Inflamm Bowel Dis. 2021 01 19; 27(2):203-206. PMID: 32152624; PMCID: PMC7813748.
      Citations: 13     Fields:    Translation:Humans
    163. Patel P, Gao G, Gulotta G, Dalal S, Cohen RD, Sakuraba A, Rubin DT, Pekow J. Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2021 01 19; 27(2):236-241. PMID: 32219391; PMCID: PMC7813746.
      Citations: 5     Fields:    Translation:Humans
    164. Shaffer SR, Huang E, Patel S, Rubin DT. Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis. Am J Gastroenterol. 2021 01 01; 116(1):125-133. PMID: 32947317; PMCID: PMC8075066.
      Citations: 4     Fields:    Translation:Humans
    165. Ungaro RC, Kappelman MD, Rubin DT, Colombel JF. COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions. Gastroenterology. 2021 04; 160(5):1447-1451. PMID: 33387525; PMCID: PMC7832021.
      Citations: 10     Fields:    Translation:HumansCells
    166. Christensen B, Rubin DT. Reply. Clin Gastroenterol Hepatol. 2021 11; 19(11):2452-2454. PMID: 33278575.
      Citations:    Fields:    
    167. Schreiber S, Dignass A, Rogge A, Rubin DT. Stopping Clinical Trials in Inflammatory Bowel Disease During the COVID-19 Pandemic Is Not a Responsible Act. J Crohns Colitis. 2020 Dec 02; 14(12):1765-1768. PMID: 32582946; PMCID: PMC7337647.
      Citations:    Fields:    Translation:HumansPHPublic Health
    168. Akiyama S, Rai V, Rubin DT. Pouchitis in inflammatory bowel disease: a review of diagnosis, prognosis, and treatment. Intest Res. 2021 Jan; 19(1):1-11. PMID: 33138344; PMCID: PMC7873408.
      Citations: 7     
    169. Van Pelt A, Glick HA, Yang W, Rubin D, Feldman M, Kimmel SE. Evaluation of COVID-19 Testing Strategies for Repopulating College and University Campuses: A Decision Tree Analysis. J Adolesc Health. 2021 01; 68(1):28-34. PMID: 33153883; PMCID: PMC7606071.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    170. Narula N, Aruljothy A, Alshahrani AA, Fadida M, Al-Saedi M, Marshall JK, Rubin DT, Christensen B. Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission. Aliment Pharmacol Ther. 2020 12; 52(11-12):1676-1682. PMID: 33131108.
      Citations: 5     Fields:    Translation:Humans
    171. Hogan AK, Galligan MM, Stack NJ, Leach KF, Aredas BL, English R, Dye M, Rubin D. A Tertiary Care-based Complex Care Program: Improving Care for Children With Medical Complexity. Med Care. 2020 11; 58(11):958-962. PMID: 33055568.
      Citations: 4     Fields:    Translation:Humans
    172. Ollech JE, Avni-Biron I, Glick L, Haider H, Dalal SR, Micic D, Pekow J, Yanai H, Cohen RD, Dotan I, Rubin DT, Sakuraba A. Effective Treatment of Acute Severe Ulcerative Colitis in Pregnancy Is Associated With Good Maternal and Fetal Outcomes. Clin Gastroenterol Hepatol. 2021 11; 19(11):2444-2446.e2. PMID: 33223497.
      Citations: 2     Fields:    Translation:Humans
    173. Fleshner P, Gearry R, Lakatos PL, Rubin DT, Allez M. Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic. J Crohns Colitis. 2020 Oct 21; 14(14 Suppl 3):S774-S779. PMID: 32722757; PMCID: PMC7454473.
      Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
    174. Fenster M, Alayo QA, Khatiwada A, Wang W, Dimopoulos C, Gutierrez A, Ciorba MA, Christophi GP, Hirten RP, Ha C, Beniwal-Patel P, Cohen BL, Syal G, Yarur A, Patel A, Colombel JF, Pekow J, Ungaro RC, Rubin DT, Deepak P. Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium. Clin Gastroenterol Hepatol. 2021 10; 19(10):2207-2209.e3. PMID: 33068786; PMCID: PMC8044250.
      Citations: 10     Fields:    Translation:Humans
    175. Melmed GY, Rubin DT, McGovern DPB. Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic. Gastroenterology. 2021 02; 160(3):639-644. PMID: 33065064; PMCID: PMC7553998.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    176. Christensen B, Hanauer SB, Gibson PR, Turner JR, Hart J, Rubin DT. Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes. J Crohns Colitis. 2020 Oct 05; 14(10):1345-1353. PMID: 32267926; PMCID: PMC7533894.
      Citations: 3     Fields:    Translation:Humans
    177. Lichtenstein GR, Rubin DT. Coronavirus and Patients With Inflammatory Bowel Disease: Management Strategies for the Practicing Clinician. Am J Gastroenterol. 2020 10; 115(10):1566-1569. PMID: 32833732; PMCID: PMC7499877.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    178. Kelly CR, Yen EF, Grinspan AM, Kahn SA, Atreja A, Lewis JD, Moore TA, Rubin DT, Kim AM, Serra S, Nersesova Y, Fredell L, Hunsicker D, McDonald D, Knight R, Allegretti JR, Pekow J, Absah I, Hsu R, Vincent J, Khanna S, Tangen L, Crawford CV, Mattar MC, Chen LA, Fischer M, Arsenescu RI, Feuerstadt P, Goldstein J, Kerman D, Ehrlich AC, Wu GD, Laine L. Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry. Gastroenterology. 2021 01; 160(1):183-192.e3. PMID: 33011173; PMCID: PMC8034505.
      Citations: 48     Fields:    Translation:HumansCells
    179. Shaffer SR, Witt J, Targownik LE, Kao D, Lee C, Smieliauskas F, Rubin DT, Singh H, Bernstein CN. Cost-effectiveness analysis of a fecal microbiota transplant center for treating recurrent C.difficile infection. J Infect. 2020 11; 81(5):758-765. PMID: 32980389.
      Citations: 4     Fields:    Translation:HumansCells
    180. Friedman MV, Hillen TJ, Misra S, Hildebolt CF, Rubin DA. Quantitative Variable Assessment of Patellar Instability: An MRI-Based Study. AJR Am J Roentgenol. 2020 11; 215(5):1163-1170. PMID: 32901564.
      Citations: 7     Fields:    Translation:Humans
    181. Loftus EV, Feagan BG, Panaccione R, Sandborn WJ, Sands BE, Danese S, D'Haens G, Rubin DT, Shafran I, Parfionovas A, Rogers R, Lirio RA, Colombel JF, Vermeire S. Long-term safety of vedolizumab for inflammatory bowel disease. Aliment Pharmacol Ther. 2020 10; 52(8):1353-1365. PMID: 32876349; PMCID: PMC7540482.
      Citations: 51     Fields:    Translation:HumansCTClinical Trials
    182. Rubin GA, Wan EY, Saluja D, Thomas G, Slotwiner DJ, Goldbarg S, Chaudhary S, Turitto G, Dizon J, Yarmohammadi H, Ehlert F, Rubin DA, Morrow JP, Waase M, Berman J, Kushnir A, Abrams MP, Halik C, Kumaraiah D, Schwartz A, Kirtane A, Kodali S, Goldenthal I, Garan H, Biviano A. Restructuring Electrophysiology During the COVID-19 Pandemic: A Practical Guide From a New York City Hospital Network. Crit Pathw Cardiol. 2020 09; 19(3):105-111. PMID: 32324622; PMCID: PMC7188041.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    183. Greuter T, Rieder F, Kucharzik T, Schoepfer AM, Rubin DT, Vavricka SR, Peyrin-Biroulet L. Emerging treatment options for extraintestinal manifestations in IBD. Gut. 2021 04; 70(4):796-802. PMID: 32847845; PMCID: PMC9014274.
      Citations: 26     Fields:    Translation:Humans
    184. Li K, Marano C, Zhang H, Yang F, Sandborn WJ, Sands BE, Feagan BG, Rubin DT, Friedman JR, De Hertogh G, Peyrin-Biroulet L. Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis. Gastroenterology. 2020 12; 159(6):2052-2064. PMID: 32853634.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    185. Shafer LA, Sofia MA, Rubin DT, Steinhart AH, Ng SC, Reches L, Israeli E, Bernstein CN. An International Multicenter Comparison of IBD-Related Disability and Validation of the IBDDI. Clin Gastroenterol Hepatol. 2021 12; 19(12):2524-2531. PMID: 32858200.
      Citations: 4     Fields:    Translation:Humans
    186. Krugliak Cleveland N, Masching A, Rubin DT. Hypersensitivity to IV Ustekinumab but Tolerance to Subcutaneous Ustekinumab in a Patient With Crohn's Disease. ACG Case Rep J. 2020 Aug; 7(8):e00449. PMID: 32904020; PMCID: PMC7449253.
      Citations: 3     
    187. Sood A, Singh A, Midha V, Mahajan R, Kao D, Rubin DT, Bernstein CN. Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy. Crohns Colitis 360. 2020 Oct; 2(4):otaa067. PMID: 36777748; PMCID: PMC9802301.
      Citations: 3     
    188. Stevens TW, Gecse K, Turner JR, de Hertogh G, Rubin DT, D'Haens GR. Diagnostic Accuracy of Fecal Calprotectin Concentration in Evaluating Therapeutic Outcomes of Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2021 11; 19(11):2333-2342. PMID: 32801008; PMCID: PMC8140548.
      Citations: 9     Fields:    Translation:Humans
    189. Wolf DC, Wolf CH, Rubin DT. Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate. Am J Gastroenterol. 2020 08; 115(8):1298. PMID: 32516203; PMCID: PMC7302082.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    190. Berger M, Yamada A, Komaki Y, Komaki F, Cohen RD, Dalal S, Hurst RD, Hyman N, Pekow J, Shogan BD, Umanskiy K, Rubin DT, Sakuraba A, Micic D. Low Skeletal Muscle Index Adjusted for Body Mass Index Is an Independent Risk Factor for Inflammatory Bowel Disease Surgical Complications. Crohns Colitis 360. 2020 Jul; 2(3):otaa064. PMID: 36776498; PMCID: PMC9802466.
      Citations: 3     
    191. Ollech JE, Normatov I, Peleg N, Dalal SR, Pekow J, Micic D, Cohen RD, Rubin DT, Sakuraba A. Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitis. Int J Colorectal Dis. 2020 Nov; 35(11):2113-2116. PMID: 32710391.
      Citations: 1     Fields:    Translation:Humans
    192. Sofia MA, Lipowska AM, Zmeter N, Perez E, Kavitt R, Rubin DT. Poor Sleep Quality in Crohn's Disease Is Associated With Disease Activity and Risk for Hospitalization or Surgery. Inflamm Bowel Dis. 2020 07 17; 26(8):1251-1259. PMID: 31820780; PMCID: PMC7365809.
      Citations: 15     Fields:    Translation:Humans
    193. Anyane-Yeboa A, Li B, Traboulsi C, Erondu AI, Sossenheimer P, Rai V, Rubin DT. Black Race and Public Insurance Are Predictive of Inappropriate Evaluation of Iron Deficiency Anemia and Diarrhea. Dig Dis Sci. 2021 07; 66(7):2200-2206. PMID: 32638203.
      Citations: 2     Fields:    Translation:Humans
    194. Deepak P, Alayo QA, Khatiwada A, Lin B, Fenster M, Dimopoulos C, Bader G, Weisshof R, Jacobs M, Gutierrez A, Ciorba MA, Christophi GP, Patel A, Hirten RP, Colombel JF, Rubin DT, Ha C, Beniwal-Patel P, Ungaro RC, Syal G, Pekow J, Cohen BL, Yarur A. Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2021 08; 19(8):1592-1601.e3. PMID: 32629130; PMCID: PMC7779667.
      Citations: 27     Fields:    Translation:Humans
    195. Rubin D, Huang J, Fisher BT, Gasparrini A, Tam V, Song L, Wang X, Kaufman J, Fitzpatrick K, Jain A, Griffis H, Crammer K, Morris J, Tasian G. Association of Social Distancing, Population Density, and Temperature With the Instantaneous Reproduction Number of SARS-CoV-2 in Counties Across the United States. JAMA Netw Open. 2020 07 01; 3(7):e2016099. PMID: 32701162; PMCID: PMC7378754.
      Citations: 71     Fields:    Translation:HumansCellsPHPublic Health
    196. Park KT, Ehrlich OG, Allen JI, Meadows P, Szigethy EM, Henrichsen K, Kim SC, Lawton RC, Murphy SM, Regueiro M, Rubin DT, Engel-Nitz NM, Heller CA. Corrigendum to The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation. Inflamm Bowel Dis. 2020 06 18; 26(7):1118. PMID: 32374862; PMCID: PMC7301401.
      Citations: 6     Fields:    
    197. Rosen MH, Axelrad J, Hudesman D, Rubin DT, Chang S. Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature. Inflamm Bowel Dis. 2020 06 18; 26(7):971-973. PMID: 32393973; PMCID: PMC7239163.
      Citations: 24     Fields:    Translation:HumansCellsPHPublic Health
    198. Neumann H, Bokemeyer B, Guda N, Tajiri H, Matsumoto T, Rubin DT, Emura F. Practical advice for management of inflammatory bowel diseases patients during the COVID-19 pandemic: World Endoscopy Organization Statement. Dig Endosc. 2020 Jul; 32(5):658-662. PMID: 32369646.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    199. Al-Ani AH, Prentice RE, Rentsch CA, Johnson D, Ardalan Z, Heerasing N, Garg M, Campbell S, Sasadeusz J, Macrae FA, Ng SC, Rubin DT, Christensen B. Review article: prevention, diagnosis and management of COVID-19 in the IBD patient. Aliment Pharmacol Ther. 2020 07; 52(1):54-72. PMID: 32348598; PMCID: PMC7267115.
      Citations: 54     Fields:    Translation:HumansCellsPHPublic Health
    200. Gondal B, Haider H, Komaki Y, Komaki F, Micic D, Rubin DT, Sakuraba A. Efficacy of various endoscopic modalities in detecting dysplasia in ulcerative colitis: A systematic review and network meta-analysis. World J Gastrointest Endosc. 2020 May 16; 12(5):159-171. PMID: 32477450; PMCID: PMC7243576.
      Citations: 5     
    201. Wang J, Prenner J, Wang W, Sakuraba A, Hyman N, Dalal S, Hurst R, Cohen RD, Umanskiy K, Shogan BD, Alpert L, Rubin DT, Colwell J, Pekow J. Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2020 06; 51(12):1365-1372. PMID: 32383278.
      Citations: 4     Fields:    Translation:Humans
    202. Rubin GA, Biviano A, Dizon J, Yarmohammadi H, Ehlert F, Saluja D, Rubin DA, Morrow JP, Waase M, Berman J, Kushnir A, Abrams MP, Garan H, Wan EY. Performance of electrophysiology procedures at an academic medical center amidst the 2020 coronavirus (COVID-19) pandemic. J Cardiovasc Electrophysiol. 2020 06; 31(6):1249-1254. PMID: 32281214; PMCID: PMC7262273.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    203. Rubin DT, Feuerstein JD, Wang AY, Cohen RD. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary. Gastroenterology. 2020 Jul; 159(1):350-357. PMID: 32283100; PMCID: PMC7151253.
      Citations: 125     Fields:    Translation:HumansCellsPHPublic Health
    204. Rubin DT, Abreu MT, Rai V, Siegel CA, International Organization for the Study of Inflammatory Bowel Disease. Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting. Gastroenterology. 2020 Jul; 159(1):6-13.e6. PMID: 32272113; PMCID: PMC7194599.
      Citations: 115     Fields:    Translation:HumansCellsPHPublic Health
    205. Akiyama S, Traboulsi C, Rai V, Rubin DT. Re: 18F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis: a randomized controlled trial. Eur J Nucl Med Mol Imaging. 2020 09; 47(10):2247. PMID: 32242252.
      Citations: 1     Fields:    Translation:Humans
    206. Sharp D, Ringer S, Park KT, Tole S, Rubin DT, Regueiro M. Listening to the Patient: Improving the Design and Conduct of Clinical Trials in Inflammatory Bowel Diseases. Crohns Colitis 360. 2020 Jan; 2(1):otaa011. PMID: 36777962; PMCID: PMC9802181.
      Citations: 2     
    207. Kelleher KJ, Rubin D, Hoagwood K. Policy and Practice Innovations to Improve Prescribing of Psychoactive Medications for Children. Psychiatr Serv. 2020 07 01; 71(7):706-712. PMID: 32188362.
      Citations: 5     Fields:    Translation:Humans
    208. Ollech JE, Normatov I, Peleg N, Wang J, Patel SA, Rai V, Yi Y, Singer J, Dalal SR, Sakuraba A, Cohen RD, Rubin DT, Pekow J. Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn's Disease. Clin Gastroenterol Hepatol. 2021 01; 19(1):104-110. PMID: 32109634; PMCID: PMC8665415.
      Citations: 28     Fields:    Translation:Humans
    209. Panchal H, Shamsunder MG, Sheinin A, Sheckter CC, Berlin NL, Nelson JA, Allen R, Rubin D, Kozlow JH, Matros E. Impact of Physician Payments on Microvascular Breast Reconstruction: An All-Payer Claim Database Analysis. Plast Reconstr Surg. 2020 Feb; 145(2):333-339. PMID: 31985616; PMCID: PMC7048410.
      Citations: 2     Fields:    Translation:Humans
    210. Rao VL, Feld LD, Rubin DT. Periendoscopic code status. Gastrointest Endosc. 2020 02; 91(2):453. PMID: 32036948.
      Citations:    Fields:    Translation:Humans
    211. Kaur M, Dalal RL, Shaffer S, Schwartz DA, Rubin DT. Inpatient Management of Inflammatory Bowel Disease-Related Complications. Clin Gastroenterol Hepatol. 2020 05; 18(6):1346-1355. PMID: 31927105.
      Citations: 16     Fields:    Translation:Humans
    212. Lewis JD, Rutgeerts P, Feagan BG, D'haens G, Danese S, Colombel JF, Reinisch W, Rubin DT, Selinger C, Bewtra M, Barcomb L, Lacerda AP, Wallace K, Butler JW, Wu M, Zhou Q, Liao X, Sandborn WJ. Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease. Inflamm Bowel Dis. 2020 01 06; 26(2):304-313. PMID: 31644790.
      Citations: 16     Fields:    Translation:Humans
    213. Gaines S, Hyoju S, Williamson AJ, van Praagh JB, Zaborina O, Rubin DT, Alverdy JC, Shogan BD, Hyman N. Infliximab Does Not Promote the Presence of Collagenolytic Bacteria in a Mouse Model of Colorectal Anastomosis. J Gastrointest Surg. 2020 11; 24(11):2637-2642. PMID: 31898107; PMCID: PMC7931774.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    214. Pasha SF, Pennazio M, Rondonotti E, Wolf D, Buras MR, Cohen SA, D'Haens G, Eliakim R, Rubin DT, Leighton JA, Albert JG, Cotter J. Capsule Retention in Crohn's Disease: A Meta-analysis. Inflamm Bowel Dis. 2020 01 01; 26(1):33-42. PMID: 31050736.
      Citations: 19     Fields:    Translation:Humans
    215. Park KT, Ehrlich OG, Allen JI, Meadows P, Szigethy EM, Henrichsen K, Kim SC, Lawton RC, Murphy SM, Regueiro M, Rubin DT, Engel-Nitz NM, Heller CA. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation. Inflamm Bowel Dis. 2020 01 01; 26(1):1-10. PMID: 31112238; PMCID: PMC7534391.
      Citations: 143     Fields:    Translation:Humans
    216. Ollech JE, Dwadasi S, Rai V, Peleg N, Normatov I, Israel A, Sossenheimer PH, Christensen B, Pekow J, Dalal SR, Sakuraba A, Cohen RD, Rubin DT. Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis. Aliment Pharmacol Ther. 2020 03; 51(6):637-643. PMID: 31875986.
      Citations: 22     Fields:    Translation:Humans
    217. Christensen B, Erlich J, Gibson PR, Turner JR, Hart J, Rubin DT. Histologic Healing Is More Strongly Associated with Clinical Outcomes in Ileal Crohn's Disease than Endoscopic Healing. Clin Gastroenterol Hepatol. 2020 10; 18(11):2518-2525.e1. PMID: 31812654; PMCID: PMC7586726.
      Citations: 25     Fields:    Translation:Humans
    218. Lei DK, Ollech JE, Andersen M, Weisshof R, Zmeter N, Sossenheimer P, Rubin DT. Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence. Am J Gastroenterol. 2019 12; 114(12):1904-1908. PMID: 31714359.
      Citations: 12     Fields:    Translation:HumansCells
    219. Rubin DT. Restarting Biologic Agents After a Drug Holiday. Gastroenterol Hepatol (N Y). 2019 Nov; 15(11):612-615. PMID: 31802986; PMCID: PMC6883732.
      Citations: 7     
    220. Bertucci Zoccali M, Hyman NH, Skowron KB, Rubin M, Cannon LM, Hurst RD, Umanskiy K, Rubin DT, Shogan BD. Exposure to Anti-tumor Necrosis Factor Medications Increases the Incidence of Pouchitis After Restorative Proctocolectomy in Patients With Ulcerative Colitis. Dis Colon Rectum. 2019 11; 62(11):1344-1351. PMID: 31596761.
      Citations: 9     Fields:    Translation:Humans
    221. Micic D, Rao VL, Rubin DT. Clinical Approach to Lactose Intolerance. JAMA. 2019 Oct 22; 322(16):1600-1601. PMID: 31556907.
      Citations: 3     Fields:    
    222. Glick LR, Sossenheimer PH, Ollech JE, Cohen RD, Hyman NH, Hurst RD, Rubin DT. Low-Dose Metronidazole is Associated With a Decreased Rate of Endoscopic Recurrence of Crohn's Disease After Ileal Resection: A Retrospective Cohort Study. J Crohns Colitis. 2019 Sep 19; 13(9):1158-1162. PMID: 30809655; PMCID: PMC6939874.
      Citations: 14     Fields:    Translation:HumansPHPublic Health
    223. Weisshof R, Ollech JE, El Jurdi K, Yvellez OV, Cohen RD, Sakuraba A, Dalal S, Pekow J, Rubin DT. Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe. J Crohns Colitis. 2019 Sep 19; 13(9):1105-1110. PMID: 30726894; PMCID: PMC7327272.
      Citations: 12     Fields:    Translation:Humans
    224. Brixner D, Mittal M, Rubin DT, Mease P, Liu HH, Davis M, Ganguli A, Fendrick AM. Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population. Patient Prefer Adherence. 2019; 13:1545-1556. PMID: 31571837; PMCID: PMC6750846.
      Citations: 6     
    225. Wang W, Cleveland NK, Ollech J, Rubin DT. Use of Tofacitinib for the Treatment of Arthritis Associated With Ulcerative Colitis. ACG Case Rep J. 2019 Sep; 6(9):e00226. PMID: 31750389; PMCID: PMC6831149.
      Citations: 7     
    226. Malter LB, Israel A, Rubin DT. Proposal to Update the Curriculum in Inflammatory Bowel Diseases for Categorical Gastroenterology Fellows. Inflamm Bowel Dis. 2019 08 20; 25(9):1443-1449. PMID: 31115448.
      Citations: 1     Fields:    Translation:Humans
    227. Buisson A, Mak WY, Andersen MJ, Lei D, Kahn SA, Pekow J, Cohen RD, Zmeter N, Rubin DT, Pereira B. Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases. J Crohns Colitis. 2019 Aug 14; 13(8):1012-1024. PMID: 30726887; PMCID: PMC6939876.
      Citations: 17     Fields:    Translation:HumansPHPublic Health
    228. Pekow J, Hernandez K, Meckel K, Deng Z, Haider HI, Khalil A, Zhang C, Talisila N, Siva S, Jasmine F, Li YC, Rubin DT, Hyman N, Bissonnette M, Weber C, Kibriya MG. IBD-associated Colon Cancers Differ in DNA Methylation and Gene Expression Profiles Compared With Sporadic Colon Cancers. J Crohns Colitis. 2019 Jul 25; 13(7):884-893. PMID: 30753380; PMCID: PMC7327274.
      Citations: 12     Fields:    Translation:HumansCells
    229. Wang Y, Wang J, Pekow J, Dalal S, Cohen RD, Ollech J, Israel A, Shogan BD, Micic D, Cannon L, Umanskiy K, Hurst R, Hyman N, Rubin DT, Sakuraba A. Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission. J Gastroenterol Hepatol. 2019 Dec; 34(12):2090-2095. PMID: 31169926.
      Citations: 4     Fields:    Translation:Humans
    230. Israel A, Christensen B, El Jurdi K, Rai V, Ollech JE, Cohen RD, Sakuraba A, Dalal SR, Rubin DT. Follow-Up of Patients With Ulcerative Colitis and Histological Normalization. Clin Gastroenterol Hepatol. 2020 04; 18(4):987-988.e1. PMID: 31228567; PMCID: PMC6923607.
      Citations: 2     Fields:    Translation:Humans
    231. Boeri M, Myers K, Ervin C, Marren A, DiBonaventura M, Cappelleri JC, Hauber B, Rubin DT. Patient and physician preferences for ulcerative colitis treatments in the United States. Clin Exp Gastroenterol. 2019; 12:263-278. PMID: 31354328; PMCID: PMC6572717.
      Citations: 10     
    232. Ollech JE, Rubin DT, Glick L, Weisshof R, El Jurdi K, Israel A, Krugliak Cleveland N, Hyman N, Sakuraba A, Pekow J, Cohen RD, Dalal SR. Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis. Dig Dis Sci. 2019 12; 64(12):3596-3601. PMID: 31187322; PMCID: PMC6858501.
      Citations: 19     Fields:    Translation:Humans
    233. Israel A, Jurdi KE, Rubin DT. Treatment De-Escalation in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2019 Jun; 15(6):335-341. PMID: 31391803; PMCID: PMC6676361.
      Citations: 4     
    234. Scott FI, Rubin DT, Kugathasan S, Bousvaros A, Elson CO, Newberry RD, Melmed GY, Pekow J, Fleshman JW, Boyle BM, Mahadevan U, Cannon LM, Long MD, Cross RK, Ha CY, Lasch KL, Robinson AM, Rafferty JF, Lee JJ, Dahl KDC, Weaver A, Shtraizent N, Honig G, Heller CA, Hurtado-Lorenzo A. Challenges in IBD Research: Pragmatic Clinical Research. Inflamm Bowel Dis. 2019 05 16; 25(Suppl 2):S40-S47. PMID: 31095704.
      Citations: 14     Fields:    Translation:Humans
    235. Brixner D, Rubin DT, Mease P, Mittal M, Liu H, Davis M, Ganguli A, Fendrick AM. Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending. J Manag Care Spec Pharm. 2019 Jul; 25(7):770-779. PMID: 31081461; PMCID: PMC10398065.
      Citations: 19     Fields:    Translation:Humans
    236. Alpert L, Yassan L, Poon R, Kadri S, Niu N, Patil SA, Mujacic I, Montes D, Galbo F, Wurst MN, Zhen CJ, Cohen RD, Rubin DT, Pekow JR, Weber CR, Xiao SY, Hart J, Segal J, Setia N. Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers. Hum Pathol. 2019 07; 89:44-50. PMID: 31054900.
      Citations: 11     Fields:    Translation:Humans
    237. Long MD, Rubin DT. Histologic Remission in Ulcerative Colitis: Are We There Yet? Am J Gastroenterol. 2019 05; 114(5):713-715. PMID: 31021831.
      Citations: 2     Fields:    Translation:Humans
    238. He L, Du J, Chen Y, Liu C, Zhou M, Adhikari S, Rubin DT, Pekow J, Li YC. Renin-angiotensin system promotes colonic inflammation by inducing TH17 activation via JAK2/STAT pathway. Am J Physiol Gastrointest Liver Physiol. 2019 06 01; 316(6):G774-G784. PMID: 30995068; PMCID: PMC6620584.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    239. Dwadasi S, Israel A, Rubin DT. The Era of Anti-Tumor Necrosis Factor Is Over. What Do We Know, What Don't We Know, and What Do We Yearn to Know? Gastrointest Endosc Clin N Am. 2019 Jul; 29(3):405-419. PMID: 31078244.
      Citations:    Fields:    Translation:Humans
    240. Aharoni Golan M, Weisshof R, Wang Y, Rubin DT. New Diagnosis of Acquired Immunodeficiency Syndrome in a Patient With Crohn's Disease. ACG Case Rep J. 2019 Apr; 6(4):e00056. PMID: 31616737; PMCID: PMC6658050.
      Citations: 1     
    241. Sossenheimer PH, Glick LR, Dachman AH, Skowron KB, Rubin MA, Umanskiy K, Smith R, Cannon LM, Hurst RD, Cohen RD, Hyman NH, Rubin DT. Abnormal Pouchogram Predicts Pouch Failure Even in Asymptomatic Patients. Dis Colon Rectum. 2019 04; 62(4):463-469. PMID: 30540661.
      Citations: 9     Fields:    Translation:Humans
    242. Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019 03; 114(3):384-413. PMID: 30840605.
      Citations: 469     Fields:    Translation:Humans
    243. Rao VL, Feld LD, Rubin DT. Discussion of Code Status in the Peri-Endoscopic Period. Am J Gastroenterol. 2019 03; 114(3):372-374. PMID: 30333550.
      Citations:    Fields:    Translation:Humans
    244. Swaminath A, Berlin EP, Cheifetz A, Hoffenberg E, Kinnucan J, Wingate L, Buchanan S, Zmeter N, Rubin DT. The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information. Inflamm Bowel Dis. 2019 02 21; 25(3):427-435. PMID: 30358848; PMCID: PMC7534377.
      Citations: 21     Fields:    Translation:Humans
    245. Weisshof R, Aharoni Golan M, Sossenheimer PH, El Jurdi K, Ollech JE, Pekow J, Cohen RD, Sakuraba A, Dalal S, Rubin DT. Real-World Experience with Tofacitinib in IBD at a Tertiary Center. Dig Dis Sci. 2019 07; 64(7):1945-1951. PMID: 30734234; PMCID: PMC6935176.
      Citations: 31     Fields:    Translation:Humans
    246. Ollech JE, Aharoni-Golan M, Weisshof R, Normatov I, Sapp AR, Kalakonda A, Israel A, Glick LR, Karrison T, Dalal SR, Sakuraba A, Cohen RD, Rubin DT, Pekow J. Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's disease. Gastrointest Endosc. 2019 08; 90(2):269-275. PMID: 30738034; PMCID: PMC6774247.
      Citations: 11     Fields:    Translation:Humans
    247. Borden BA, Lee SM, Danahey K, Galecki P, Patrick-Miller L, Siegler M, Sorrentino MJ, Sacro Y, Davis AM, Rubin DT, Lipstreuer K, Polonsky TS, Nanda R, Harper WR, Koyner JL, Burnet DL, Stadler WM, Kavitt RT, Meltzer DO, Ratain MJ, O'Donnell PH. Patient-provider communications about pharmacogenomic results increase patient recall of medication changes. Pharmacogenomics J. 2019 12; 19(6):528-537. PMID: 30713337; PMCID: PMC6980369.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    248. Feagan BG, Sandborn WJ, Byrne SO, Khalid JM, Kempf C, Geransar P, Bhayat F, Rubin DT, Colombel JF. Incidence of Arthritis/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials. J Crohns Colitis. 2019 Jan 01; 13(1):50-57. PMID: 30203005; PMCID: PMC6302953.
      Citations: 24     Fields:    Translation:HumansCTClinical Trials
    249. Micic D, Komaki Y, Alavanja A, Rubin DT, Sakuraba A. Risk of Cancer Recurrence Among Individuals Exposed to Antitumor Necrosis Factor Therapy: A Systematic Review and Meta-Analysis of Observational Studies. J Clin Gastroenterol. 2019 01; 53(1):e1-e11. PMID: 28737645; PMCID: PMC5776073.
      Citations: 8     Fields:    Translation:Humans
    250. Lindsay JO, Sands BE, Su C, Friedman G, Zhang H, Yarlas A, Bayliss M, Maher S, Cappelleri JC, Bushmakin AG, Rubin DT, Panés J, Vermeire S. Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies. J Crohns Colitis. 2019 01 01; 13(1):139-140. PMID: 30412228; PMCID: PMC6302951.
      Citations: 5     Fields:    
    251. Feld LD, Rubin DT, Feld AD. Legal Risks and Considerations Associated with Inflammatory Bowel Disease: A Primer. Am J Gastroenterol. 2018 11; 113(11):1577-1579. PMID: 30008471.
      Citations: 2     Fields:    Translation:Humans
    252. Weisshof R, El Jurdi K, Zmeter N, Rubin DT. Emerging Therapies for Inflammatory Bowel Disease. Adv Ther. 2018 11; 35(11):1746-1762. PMID: 30374806; PMCID: PMC6224002.
      Citations: 34     Fields:    Translation:Humans
    253. Reinisch W, Gottlieb K, Colombel JF, Danese S, Panaccione R, Panes J, Peyrin-Biroulet L, Rubin D, Sands BE, Vermeire S, Mulberg A, Sandborn B, Schreiber S. Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development. Clin Gastroenterol Hepatol. 2019 08; 17(9):1673-1679.e1. PMID: 31352970.
      Citations: 8     Fields:    Translation:Humans
    254. Krugliak Cleveland N, Rubin DT. Response. Gastrointest Endosc. 2018 10; 88(4):783-784. PMID: 30217250.
      Citations:    Fields:    
    255. Sheckter CC, Panchal HJ, Razdan SN, Rubin D, Yi D, Disa JJ, Mehrara B, Matros E. The Influence of Physician Payments on the Method of Breast Reconstruction: A National Claims Analysis. Plast Reconstr Surg. 2018 10; 142(4):434e-442e. PMID: 29979366; PMCID: PMC6156943.
      Citations: 11     Fields:    Translation:Humans
    256. Micic D, Yarur A, Gonsalves A, Rao VL, Broadaway S, Cohen R, Dalal S, Gaetano JN, Glick LR, Hirsch A, Pekow J, Sakuraba A, Walk ST, Rubin DT. Correction to: Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study. Dig Dis Sci. 2018 10; 63(10):2815. PMID: 30136047.
      Citations:    Fields:    
    257. Colman RJ, Lawton RC, Dubinsky MC, Rubin DT. Methotrexate for the Treatment of Pediatric Crohn's Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2018 09 15; 24(10):2135-2141. PMID: 29688409; PMCID: PMC6994018.
      Citations: 9     Fields:    Translation:Humans
    258. Raffals LE, Nguyen GC, Rubin DT. Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2019 04; 17(5):818-823. PMID: 30196164.
      Citations: 5     Fields:    Translation:Humans
    259. Anyane-Yeboa A, Yamada A, Haider H, Wang Y, Komaki Y, Komaki F, Pekow J, Dalal S, Cohen RD, Cannon L, Umanskiy K, Smith R, Hurst R, Hyman N, Rubin DT, Sakuraba A. A comparison of the risk of postoperative recurrence between African-American and Caucasian patients with Crohn's disease. Aliment Pharmacol Ther. 2018 11; 48(9):933-940. PMID: 30126019; PMCID: PMC6669906.
      Citations: 5     Fields:    Translation:Humans
    260. Melmed GY, Dubinsky MC, Rubin DT, Fleisher M, Pasha SF, Sakuraba A, Tiongco F, Shafran I, Fernandez-Urien I, Papageorgiou NP, Leighton JA, Rosa B. Utility of video capsule endoscopy for longitudinal monitoring of Crohn's disease activity in the small bowel: a prospective study. Gastrointest Endosc. 2018 12; 88(6):947-955.e2. PMID: 30086261.
      Citations: 15     Fields:    Translation:Humans
    261. Wang J, Bhatia A, Krugliak Cleveland N, Gupta N, Dalal S, Rubin DT, Sakuraba A. Rapid Onset of Inflammatory Bowel Disease after Receiving Secukinumab Infusion. ACG Case Rep J. 2018; 5:e56. PMID: 30105273; PMCID: PMC6072803.
      Citations: 31     
    262. Micic D, Hirsch A, Setia N, Rubin DT. Enteric infections complicating ulcerative colitis. Intest Res. 2018 Jul; 16(3):489-493. PMID: 30090049; PMCID: PMC6077301.
      Citations: 3     
    263. Yarur AJ, Gondal B, Hirsch A, Christensen B, Cohen RD, Rubin DT. Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases. J Clin Gastroenterol. 2018 07; 52(6):537-544. PMID: 28723860.
      Citations: 7     Fields:    Translation:HumansCells
    264. Schöffel N, Liehr RM, Bünger C, Krüger K, Rubin D. [Nephrotic syndrome and microhematuria in a patient with nutcracker syndrome: Report of a case and review of the literature]. Internist (Berl). 2018 06; 59(6):608-614. PMID: 29181552.
      Citations:    Fields:    Translation:Humans
    265. Patel P, Yarur A, Dalal S, Sakuraba A, Rubin DT, Hanauer SB, Hanan I, Raffals LH, Cohen RD, Pekow J. Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy. Inflamm Bowel Dis. 2018 05 18; 24(6):1291-1297. PMID: 29506124; PMCID: PMC7190889.
      Citations:    Fields:    Translation:Humans
    266. Krugliak Cleveland N, Ollech JE, Colman RJ, Rodriquez D, Hirsch A, Cohen RD, Hanauer SB, Hart J, Hurst R, Rubin DT. Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia. Clin Gastroenterol Hepatol. 2019 01; 17(1):205-206. PMID: 29751167; PMCID: PMC7034413.
      Citations: 9     Fields:    Translation:Humans
    267. Christensen B, Gibson PR, Micic D, Colman RJ, Goeppinger SR, Kassim O, Yarur A, Weber CR, Cohen RD, Rubin DT. Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2019 02; 17(3):486-493. PMID: 29751166; PMCID: PMC7034423.
      Citations: 35     Fields:    Translation:Humans
    268. Christensen B, Gibson PR, Rubin DT. Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply. Aliment Pharmacol Ther. 2018 05; 47(10):1423-1424. PMID: 29676007.
      Citations: 3     Fields:    Translation:Humans
    269. Feagan BG, Schwartz D, Danese S, Rubin DT, Lissoos TW, Xu J, Lasch K. Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2. J Crohns Colitis. 2018 Apr 27; 12(5):621-626. PMID: 29471381; PMCID: PMC6018899.
      Citations: 32     Fields:    Translation:HumansCTClinical Trials
    270. Weisshof R, Golan MA, Yvellez OV, Rubin DT. The use of tofacitinib in the treatment of inflammatory bowel disease. Immunotherapy. 2018 08; 10(10):837-849. PMID: 29701124.
      Citations: 1     Fields:    Translation:Humans
    271. Yarlas A, Rubin DT, Lindsay JO, Bayliss M, Cappelleri JC, Maher S, Bushmakin AG, Chen LA, DiBonaventura M, Panés J, Vermeire S. Burden of Ulcerative Colitis on Functioning and Well-being: A Systematic Literature Review of the SF-36® Health Survey. J Crohns Colitis. 2018 Apr 27; 12(5):600-609. PMID: 29718244.
      Citations: 28     Fields:    Translation:Humans
    272. Pekow J, Meckel K, Dougherty U, Haider HI, Deng Z, Hart J, Rubin DT, Bissonnette M. Increased mucosal expression of miR-215 precedes the development of neoplasia in patients with long-standing ulcerative colitis. Oncotarget. 2018 Apr 17; 9(29):20709-20720. PMID: 29755683; PMCID: PMC5945498.
      Citations: 2     Fields:    
    273. Skowron KB, Shogan BD, Rubin DT, Hyman NH. The New Frontier: the Intestinal Microbiome and Surgery. J Gastrointest Surg. 2018 07; 22(7):1277-1285. PMID: 29633119.
      Citations: 4     Fields:    Translation:Humans
    274. Wali RK, Bianchi L, Kupfer S, De La Cruz M, Jovanovic B, Weber C, Goldberg MJ, Rodriguez LM, Bergan R, Rubin D, Tull MB, Richmond E, Parker B, Khan S, Roy HK. Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trial. PLoS One. 2018; 13(4):e0193544. PMID: 29617381; PMCID: PMC5884487.
      Citations:    Fields:    Translation:Humans
    275. Danese S, Bonovas S, Fiorino G, Sandborn WJ, Rubin DT, Kamm MA, Colombel JF, Sands BE, Vermeire S, Rogler G, D'Haens G, Lopez A, Panes J, Peyrin-Biroulet L. Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease. Gastroenterology. 2018 07; 155(1):76-87. PMID: 29601825.
      Citations: 19     Fields:    Translation:Humans
    276. Christensen B, Colman RJ, Micic D, Gibson PR, Goeppinger SR, Yarur A, Weber CR, Cohen RD, Rubin DT. Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety. Inflamm Bowel Dis. 2018 03 19; 24(4):849-860. PMID: 29562271; PMCID: PMC6196763.
      Citations: 12     Fields:    Translation:Humans
    277. Mak WY, Buisson A, Andersen MJ, Lei D, Pekow J, Cohen RD, Kahn SA, Rubin DT, Pereira B. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis. Dig Dis Sci. 2018 May; 63(5):1294-1301. PMID: 29468374.
      Citations: 26     Fields:    Translation:Humans
    278. Yamada A, Komaki Y, Patel N, Komaki F, Pekow J, Dalal S, Cohen RD, Cannon L, Umanskiy K, Smith R, Hurst R, Hyman N, Rubin DT, Sakuraba A. The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease. Inflamm Bowel Dis. 2018 02 15; 24(3):502-509. PMID: 29462385.
      Citations: 20     Fields:    Translation:HumansPHPublic Health
    279. Micic D, Yarur A, Gonsalves A, Rao VL, Broadaway S, Cohen R, Dalal S, Gaetano JN, Glick LR, Hirsch A, Pekow J, Sakuraba A, Walk ST, Rubin DT. Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study. Dig Dis Sci. 2018 04; 63(4):1016-1024. PMID: 29417331.
      Citations: 5     Fields:    Translation:HumansCells
    280. Christensen B, Micic D, Gibson PR, Yarur A, Bellaguarda E, Corsello P, Gaetano JN, Kinnucan J, Rao VL, Reddy S, Singh S, Pekow J, Rubin DT. Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease. Aliment Pharmacol Ther. 2018 Mar; 47(6):753-762. PMID: 29377235; PMCID: PMC5821055.
      Citations: 22     Fields:    Translation:Humans
    281. Lindsay JO, Sands BE, Su C, Friedman G, Zhang H, Yarlas A, Bayliss M, Maher S, Cappelleri JC, Bushmakin AG, Rubin DT, Panés J, Vermeire S. Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies. J Crohns Colitis. 2018 Jan 24; 12(2):145-156. PMID: 29028981; PMCID: PMC5881763.
      Citations: 39     Fields:    Translation:HumansCTClinical Trials
    282. Krugliak Cleveland N, Huo D, Sadiq F, Sofia MA, Marks J, Cohen RD, Hanauer SB, Turner J, Hart J, Rubin DT. Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease. Gastrointest Endosc. 2018 May; 87(5):1304-1309. PMID: 29307473; PMCID: PMC9646239.
      Citations: 4     Fields:    Translation:Humans
    283. Rubin DT, Cohen RD, Sandborn WJ, Lichtenstein GR, Axler J, Riddell RH, Zhu C, Barrett AC, Bortey E, Forbes WP. Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial. J Crohns Colitis. 2017 12 04; 11(12):1510. PMID: 28453665; PMCID: PMC5951008.
      Citations:    Fields:    
    284. Rubin DT, Gomberg A. Meet the Master: Joseph Barnett Kirsner (1909-2012). VideoGIE. 2017 Dec; 2(12):323-325. PMID: 29916487; PMCID: PMC6004029.
      Citations:    
    285. Rubin DT. Recent Research on Joint Pain and Arthritis in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2017 Nov; 13(11):688-690. PMID: 29230148; PMCID: PMC5717884.
      Citations: 3     
    286. Paramsothy S, Paramsothy R, Rubin DT, Kamm MA, Kaakoush NO, Mitchell HM, Castaño-Rodríguez N. Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. J Crohns Colitis. 2017 Oct 01; 11(10):1180-1199. PMID: 28486648.
      Citations: 164     Fields:    Translation:Humans
    287. Gibofsky A, Skup M, Mittal M, Johnson SJ, Davis M, Chao J, Rubin DT. Effects of non-medical switching on outcomes among patients prescribed tumor necrosis factor inhibitors. Curr Med Res Opin. 2017 11; 33(11):1945-1953. PMID: 28870101.
      Citations: 9     Fields:    Translation:Humans
    288. Micic D, Gaetano JN, Rubin JN, Cohen RD, Sakuraba A, Rubin DT, Pekow J. Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease. PLoS One. 2017; 12(8):e0182900. PMID: 28837634; PMCID: PMC5570509.
      Citations: 14     Fields:    Translation:Humans
    289. Hutchison AL, Meckel K, Harrington K, Deng Z, Talasila N, Rubin DT, Hanauer SB, Hurst R, Umanskiy K, Fichera A, Hart J, Dinner AR, Bissonnette M, Pekow J. miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling. Inflamm Bowel Dis. 2017 08; 23(8):1328-1337. PMID: 28594651; PMCID: PMC5535754.
      Citations: 16     Fields:    Translation:HumansCells
    290. Krugliak Cleveland N, Rubin DT, Hart J, Weber CR, Meckel K, Tran AL, Aelvoet AS, Pan I, Gonsalves A, Gaetano JN, Williams KM, Wroblewski K, Jabri B, Pekow J. Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon. Clin Gastroenterol Hepatol. 2018 Jan; 16(1):68-74. PMID: 28756053; PMCID: PMC5735030.
      Citations: 18     Fields:    Translation:Humans
    291. Yamada A, Komaki Y, Patel N, Komaki F, Aelvoet AS, Tran AL, Pekow J, Dalal S, Cohen RD, Cannon L, Umanskiy K, Smith R, Hurst R, Hyman N, Rubin DT, Sakuraba A. Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab. Am J Gastroenterol. 2017 Sep; 112(9):1423-1429. PMID: 28719595.
      Citations: 30     Fields:    Translation:Humans
    292. Rubin DT, Cohen RD, Sandborn WJ, Lichtenstein GR, Axler J, Riddell RH, Zhu C, Barrett AC, Bortey E, Forbes WP. Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial. J Crohns Colitis. 2017 Jul 01; 11(7):785-791. PMID: 28333362; PMCID: PMC5881669.
      Citations: 26     Fields:    Translation:Humans
    293. O'Donnell PH, Wadhwa N, Danahey K, Borden BA, Lee SM, Hall JP, Klammer C, Hussain S, Siegler M, Sorrentino MJ, Davis AM, Sacro YA, Nanda R, Polonsky TS, Koyner JL, Burnet DL, Lipstreuer K, Rubin DT, Mulcahy C, Strek ME, Harper W, Cifu AS, Polite B, Patrick-Miller L, Yeo KT, Leung E, Volchenboum SL, Altman RB, Olopade OI, Stadler WM, Meltzer DO, Ratain MJ. Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing. Clin Pharmacol Ther. 2017 Nov; 102(5):859-869. PMID: 28398598; PMCID: PMC5636653.
      Citations: 32     Fields:    Translation:Humans
    294. Pekow J, Meckel K, Dougherty U, Huang Y, Chen X, Almoghrabi A, Mustafi R, Ayaloglu-Butun F, Deng Z, Haider HI, Hart J, Rubin DT, Kwon JH, Bissonnette M. miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD. Clin Cancer Res. 2017 Sep 01; 23(17):5281-5291. PMID: 28600480; PMCID: PMC5581687.
      Citations: 47     Fields:    Translation:HumansAnimalsCells
    295. Lee STM, Kahn SA, Delmont TO, Shaiber A, Hubert NA, Morrison HG, Antonopoulos DA, Rubin DT, Eren AM, Esen ÖC. Tracking microbial colonization in fecal microbiota transplantation experiments via genome-resolved metagenomics. Microbiome. 2017 05 04; 5(1):50. PMID: 28473000; PMCID: PMC5418705.
      Citations: 45     Fields:    Translation:HumansCells
    296. Ruhnke GW, Manning WG, Rubin DT, Meltzer DO. The Drivers of Discretionary Utilization: Clinical History Versus Physician Supply. Acad Med. 2017 05; 92(5):703-708. PMID: 28441679; PMCID: PMC5407298.
      Citations: 1     Fields:    Translation:Humans
    297. Patel H, Lissoos T, Rubin DT. Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States. PLoS One. 2017; 12(4):e0175099. PMID: 28426675; PMCID: PMC5398513.
      Citations: 16     Fields:    Translation:Humans
    298. McKillip RP, Borden BA, Galecki P, Ham SA, Patrick-Miller L, Hall JP, Hussain S, Danahey K, Siegler M, Sorrentino MJ, Sacro Y, Davis AM, Rubin DT, Lipstreuer K, Polonsky TS, Nanda R, Harper WR, Koyner JL, Burnet DL, Stadler WM, Ratain MJ, Meltzer DO, O'Donnell PH. Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program. Clin Pharmacol Ther. 2017 07; 102(1):106-114. PMID: 27981566; PMCID: PMC5474215.
      Citations: 11     Fields:    Translation:Humans
    299. Vermeire S, Loftus EV, Feagan BG, Sandborn WJ, Sands BE, Danese S, D'Haens GR, Kaser A, Panaccione R, Rubin DT, Shafran I, McAuliffe M, Kaviya A, Sankoh S, Mody R, Abhyankar B, Smyth M, Colombel JF. Long-term Efficacy of Vedolizumab for Crohn's Disease. J Crohns Colitis. 2017 Apr 01; 11(4):412-424. PMID: 27683798.
      Citations: 82     Fields:    Translation:Humans
    300. Loftus EV, Feagan BG, Vermeire S, Sandborn WJ, Sands BE, Danese S, D'Haens GR, Kaser A, Panaccione R, Rubin DT, Shafran I, McAuliffe M, Kaviya A, Sankoh S, Mody R, Abhyankar B, Smyth M, Colombel JF. Long-term Efficacy of Vedolizumab for Ulcerative Colitis. J Crohns Colitis. 2017 Apr 01; 11(4):400-411. PMID: 27683800.
      Citations: 82     Fields:    Translation:HumansCTClinical Trials
    301. Sofia MA, Rubin DT. The Impact of Therapeutic Antibodies on the Management of Digestive Diseases: History, Current Practice, and Future Directions. Dig Dis Sci. 2017 04; 62(4):833-842. PMID: 28197743.
      Citations: 3     Fields:    Translation:HumansAnimals
    302. Dubinsky MC, Martino S, Hewett KA, Rubin DT, Panés J. Communication Between Physicians and Patients with Ulcerative Colitis: Reflections and Insights from a Qualitative Study of In-Office Patient-Physician Visits. Inflamm Bowel Dis. 2017 04; 23(4):494-501. PMID: 28296817; PMCID: PMC5495553.
      Citations: 22     Fields:    Translation:Humans
    303. Rubin DT, Mittal M, Davis M, Johnson S, Chao J, Skup M. Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis. J Manag Care Spec Pharm. 2017 Aug; 23(8):859-867. PMID: 28737994; PMCID: PMC10397981.
      Citations: 30     Fields:    Translation:Humans
    304. Rubin DT, Naik S, Kondragunta V, Rao T, Jain A. Detection of adalimumab and antibodies to adalimumab using a homogeneous mobility shift assay. Curr Med Res Opin. 2017 May; 33(5):837-843. PMID: 28145781.
      Citations: 2     Fields:    Translation:Humans
    305. Dalal S, Antonopoulos D, Hubert N, Raffals LH, Dolan K, Weber C, Messer JS, Jabri B, Bendelac A, Eren AM, Rubin DT, Sogin M, Chang EB, Huang Y. Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis. Inflamm Bowel Dis. 2017 03; 23(3):366-378. PMID: 28221248; PMCID: PMC5988644.
      Citations: 11     Fields:    Translation:HumansCells
    306. Christensen B, Hanauer SB, Erlich J, Kassim O, Gibson PR, Turner JR, Hart J, Rubin DT. Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes. Clin Gastroenterol Hepatol. 2017 Oct; 15(10):1557-1564.e1. PMID: 28238954; PMCID: PMC5618439.
      Citations: 63     Fields:    Translation:Humans
    307. Huang Y, Dalal S, Antonopoulos D, Hubert N, Raffals LH, Dolan K, Weber C, Messer JS, Jabri B, Bendelac A, Eren AM, Rubin DT, Sogin M, Chang EB. Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis. Inflamm Bowel Dis. 2017 Feb 13. PMID: 28248733.
      Citations:    
    308. Feld LD, Goeppinger SR, Margolese J, Rosh J, Rubin M, Kim S, Rodriquez DM, Wingate L, Rubin DT. The Crohn's and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access. Inflamm Bowel Dis. 2017 02; 23(2):224-232. PMID: 27997434.
      Citations: 13     Fields:    Translation:Humans
    309. Sofia MA, Sakuraba A, Rubin DT. Two Complex Cases of Hermansky-Pudlak Syndrome Highlight a Potential Biologic Explanation for an Associated Crohn's Disease Phenotype. ACG Case Rep J. 2017; 4:e14. PMID: 28144619; PMCID: PMC5247631.
      Citations: 3     
    310. Rubin DT, Patel H, Shi S, Mody R. Assessment of corticosteroid-related quality of care measures for ulcerative colitis and Crohn's disease in the United States: a claims data analysis. Curr Med Res Opin. 2017 03; 33(3):529-536. PMID: 27903084.
      Citations: 3     Fields:    Translation:Humans
    311. Rubin DT, Gulotta G, Wroblewski K, Pekow J, Siva S. Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017 01; 23(1):152-157. PMID: 27930412; PMCID: PMC5177471.
      Citations: 58     Fields:    Translation:Humans
    312. Rubin DT, Krugliak Cleveland N, Rodriquez DM. Outcomes of colitis-associated dysplasia after referral from the community to a tertiary center. Gastrointest Endosc. 2016 12; 84(6):1078-1079. PMID: 27855794.
      Citations: 3     Fields:    Translation:Humans
    313. Paramsothy S, Cleveland NK, Zmeter N, Rubin DT. The Role of Biosimilars in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2016 Dec; 12(12):741-751. PMID: 28035201; PMCID: PMC5193082.
      Citations: 5     
    314. Feagan BG, Patel H, Colombel JF, Rubin DT, James A, Mody R, Lasch K. Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial. Aliment Pharmacol Ther. 2017 01; 45(2):264-275. PMID: 27859410; PMCID: PMC5215718.
      Citations: 23     Fields:    Translation:Humans
    315. Vineis JH, Ringus DL, Morrison HG, Delmont TO, Dalal S, Raffals LH, Antonopoulos DA, Rubin DT, Eren AM, Chang EB, Sogin ML. Patient-Specific Bacteroides Genome Variants in Pouchitis. mBio. 2016 11 15; 7(6). PMID: 27935837; PMCID: PMC5111406.
      Citations: 21     Fields:    Translation:HumansCells
    316. Baker JC, Kyriakos M, McDonald DJ, Rubin DA. Primary Rosai-Dorfman disease of the femur. Skeletal Radiol. 2017 Jan; 46(1):129-135. PMID: 27785544.
      Citations: 10     Fields:    Translation:Humans
    317. Feagan BG, Rubin DT, Danese S, Vermeire S, Abhyankar B, Sankoh S, James A, Smyth M. Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists. Clin Gastroenterol Hepatol. 2017 02; 15(2):229-239.e5. PMID: 27639327.
      Citations: 75     Fields:    Translation:Humans
    318. Cleveland NK, Rodriquez D, Wichman A, Pan I, Melmed GY, Rubin DT. Many Inflammatory Bowel Disease Patients Are Not Immune to Measles or Pertussis. Dig Dis Sci. 2016 10; 61(10):2972-2976. PMID: 27557706.
      Citations: 19     Fields:    Translation:HumansCells
    319. Lee SD, Rubin DT, Sandborn WJ, Randall C, Younes Z, Schreiber S, Schwartz DA, Burakoff R, Binion D, Dassopoulos T, Arsenescu R, Gutierrez A, Scherl E, Kayhan C, Hasan I, Kosutic G, Spearman M, Sen D, Coarse J, Hanauer S. Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study. Inflamm Bowel Dis. 2016 08; 22(8):1870-80. PMID: 27400222; PMCID: PMC4949014.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    320. Sandborn WJ, Rubin DT, Harper JR, Bosworth BP. Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies. Inflamm Bowel Dis. 2016 08; 22(8):1881-6. PMID: 27416045; PMCID: PMC4949012.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    321. Rubin DT. Home Sweet Home? Will Medical Homes Be Coming to Your Neighborhood Sometime Soon? Inflamm Bowel Dis. 2016 08; 22(8):1981-3. PMID: 27416047.
      Citations: 1     Fields:    Translation:Humans
    322. Colman RJ, Rubin DT. Histological inflammation increases the risk of colorectal neoplasia in ulcerative colitis: a systematic review. Intest Res. 2016 Jul; 14(3):202-10. PMID: 27433141; PMCID: PMC4945523.
      Citations: 17     
    323. Katsanos KH, Micic D, Van Assche G, Lee JC, Lindsay JO, Rubin DT, Panaccione R, Torres J, Caprioli F, Lobatón T, Zerôncio M, Colombel JF. Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases. J Crohns Colitis. 2016 Dec; 10(12):1385-1394. PMID: 27282402; PMCID: PMC5174730.
      Citations: 49     Fields:    Translation:Humans
    324. Meckel K, Li YC, Lim J, Kocherginsky M, Weber C, Almoghrabi A, Chen X, Kaboff A, Sadiq F, Hanauer SB, Cohen RD, Kwon J, Rubin DT, Hanan I, Sakuraba A, Yen E, Bissonnette M, Pekow J. Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis. Am J Clin Nutr. 2016 07; 104(1):113-20. PMID: 27281309; PMCID: PMC4919525.
      Citations: 38     Fields:    Translation:Humans
    325. Shi Y, Liu T, He L, Dougherty U, Chen L, Adhikari S, Alpert L, Zhou G, Liu W, Wang J, Deb DK, Hart J, Liu SQ, Kwon J, Pekow J, Rubin DT, Zhao Q, Bissonnette M, Li YC. Activation of the Renin-Angiotensin System Promotes Colitis Development. Sci Rep. 2016 06 08; 6:27552. PMID: 27271344; PMCID: PMC4897651.
      Citations: 19     Fields:    Translation:HumansAnimalsCells
    326. Melmed GY, Irving PM, Rubin DT, Kornbluth A, Kozuch PL, Raffals LE, Velayos FS, Sparrow MP, Baidoo L, Bressler B, Cheifetz AS, Jones J, Kaplan GG, Siegel CA, Devlin SM. Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel. Inflamm Bowel Dis. 2016 06; 22(6):1418-24. PMID: 27057680.
      Citations: 4     Fields:    Translation:Humans
    327. Kahn SA, Rubin DT. When Subjects Violate the Research Covenant: Lessons Learned from a Failed Clinical Trial of Fecal Microbiota Transplantation. Am J Gastroenterol. 2016 11; 111(11):1508-1510. PMID: 27166127.
      Citations: 4     Fields:    Translation:Humans
    328. Saad AM, Czul F, Sakuraba A, Rubin DT, Cohen RD. Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease. Inflamm Bowel Dis. 2016 May; 22(5):1027-31. PMID: 26919459.
      Citations: 7     Fields:    Translation:Humans
    329. Sofia MA, Rubin DT. Current approaches for optimizing the benefit of biologic therapy in ulcerative colitis. Therap Adv Gastroenterol. 2016 Jul; 9(4):548-59. PMID: 27366223; PMCID: PMC4913335.
      Citations: 7     
    330. Ward MA, Pierre JF, Leal RF, Huang Y, Shogan B, Dalal SR, Weber CR, Leone VA, Musch MW, An GC, Rao MC, Rubin DT, Raffals LE, Antonopoulos DA, Sogin ML, Hyman NH, Alverdy JC, Chang EB. Insights into the pathogenesis of ulcerative colitis from a murine model of stasis-induced dysbiosis, colonic metaplasia, and genetic susceptibility. Am J Physiol Gastrointest Liver Physiol. 2016 06 01; 310(11):G973-88. PMID: 27079612; PMCID: PMC4935476.
      Citations: 11     Fields:    Translation:HumansAnimals
    331. Lapin B, Rubin M, Hurst RD, Rubin DT, Hyman NH, Umanskiy K, Skowron KB. Clostridium Difficile Infection in Ulcerative Colitis: Can Alteration of the Gut-associated Microbiome Contribute to Pouch Failure? Inflamm Bowel Dis. 2016 Apr; 22(4):902-11. PMID: 26891259.
      Citations: 8     Fields:    Translation:HumansCells
    332. Connor SJ, Walls DM, Gollins J, Stewart SK, Bewtra M, Baumblatt GL, Holubar SD, Greenup AJ, Sechi A, Girgis A, Rubin DT, Siegel CA, Thompson KD. Patients with Ulcerative Colitis Are More Concerned About Complications of Their Disease than Side Effects of Medications. Inflamm Bowel Dis. 2016 Apr; 22(4):940-7. PMID: 26950308.
      Citations: 11     Fields:    Translation:Humans
    333. Wichmann A, Krugliak Cleveland N, Rubin DT. Safety and Efficacy of Live Measles Vaccine Administered to a Crohn's Disease Patient Receiving Vedolizumab. Am J Gastroenterol. 2016 04; 111(4):577. PMID: 27125715.
      Citations: 7     Fields:    Translation:Humans
    334. Colman RJ, Rodriquez D, Hirsch A, Cohen RD, Hanauer SB, Hart J, Rubin DT, Krugliak Cleveland N. Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia. Inflamm Bowel Dis. 2016 Mar; 22(3):631-7. PMID: 26658214; PMCID: PMC5058785.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    335. Rubin DT, Inglis S, Magee E, Solomon D, D'Haens G, Ulcerative Colitis Remission Study Group, Bradette M, Gabalec L, Dobru D, Márquez J. Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial. J Crohns Colitis. 2016 Aug; 10(8):925-33. PMID: 26908939; PMCID: PMC4962361.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    336. Tarabar D, Hirsch A, Rubin DT. Vedolizumab in the treatment of Crohn's disease. Expert Rev Gastroenterol Hepatol. 2016; 10(3):283-90. PMID: 26810276.
      Citations: 2     Fields:    Translation:HumansAnimals
    337. Christensen B, Rubin DT. Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice. Curr Gastroenterol Rep. 2016 Jan; 18(1):5. PMID: 26759147.
      Citations: 17     Fields:    Translation:Humans
    338. Parian A, Koh J, Limketkai BN, Eluri S, Rubin DT, Brant SR, Ha CY, Bayless TM, Giardiello F, Hart J, Montgomery E, Lazarev MG. Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2016 Jul; 84(1):87-95.e1. PMID: 26709112; PMCID: PMC5555397.
      Citations: 10     Fields:    Translation:Humans
    339. Roy HK, Turzhitsky V, Wali R, Radosevich AJ, Jovanovic B, Della'Zanna G, Umar A, Rubin DT, Goldberg MJ, Bianchi L, De La Cruz M, Bogojevic A, Helenowski IB, Rodriguez L, Chatterton R, Skripkauskas S, Page K, Weber CR, Huang X, Richmond E, Bergan RC, Backman V. Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin. Gut. 2017 02; 66(2):285-292. PMID: 26503631; PMCID: PMC5108693.
      Citations: 19     Fields:    Translation:Humans
    340. Rubin DT, Sandborn WJ, Bosworth B, Zakko S, Gordon GL, Sale ME, Rolleri RL, Golden PL, Barrett AC, Bortey E, Forbes WP. Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis. Dig Dis Sci. 2015 Nov; 60(11):3408-17. PMID: 26386854; PMCID: PMC4621699.
      Citations: 7     Fields:    Translation:Humans
    341. Kinnucan J, Tomal J, Rubin DT. U.S. Patients with Ulcerative Colitis Do Not Have a Decreased Risk of Diverticulosis. Inflamm Bowel Dis. 2015 Sep; 21(9):2154-7. PMID: 26197447.
      Citations: 3     Fields:    Translation:Humans
    342. Rubin DT. Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2015 Sep; 11(9):618-20. PMID: 27482184; PMCID: PMC4965622.
      Citations: 2     
    343. Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, D'Haens G, Dotan I, Dubinsky M, Feagan B, Fiorino G, Gearry R, Krishnareddy S, Lakatos PL, Loftus EV, Munkholm P, Murdoch TB, Panaccione R, Riddell RH, Ruel J, Rubin DT, Samaan M, Siegel CA, Silverberg MS, Stoker J, Schreiber S, Travis S, Van Assche G, Danese S, O'Donnell S, Winer S, Hanauer S, Colombel JF, Peyrin-Biroulet L, Marteau P, Ordás I, Panes J, Bouguen G, Pariente B. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. Am J Gastroenterol. 2015 Sep; 110(9):1324-38. PMID: 26303131.
      Citations: 583     Fields:    Translation:Humans
    344. Hirsch A, Yarur AJ, Dezheng H, Rodriquez D, Krugliak Cleveland N, Ali T, Hurst RD, Umanskiy K, Hyman N, Colwell J, Rubin DT. Penetrating Disease, Narcotic Use, and Loop Ostomy Are Associated with Ostomy and IBD-related Complications After Ostomy Surgery in Crohn's Disease Patients. J Gastrointest Surg. 2015 Oct; 19(10):1852-61. PMID: 26264361.
      Citations: 6     Fields:    Translation:Humans
    345. Park KT, Colletti RB, Rubin DT, Sharma BK, Thompson A, Krueger A. Health Insurance Paid Costs and Drivers of Costs for Patients With Crohn's Disease in the United States. Am J Gastroenterol. 2016 Jan; 111(1):15-23. PMID: 26195179.
      Citations: 44     Fields:    Translation:Humans
    346. Mikolajczyk AE, Watson S, Surma BL, Rubin DT. Assessment of Tandem Measurements of pH and Total Gut Transit Time in Healthy Volunteers. Clin Transl Gastroenterol. 2015 Jul 09; 6:e100. PMID: 26158610; PMCID: PMC4816255.
      Citations: 7     Fields:    
    347. Hirsch A, Colman RJ, Lang GD, Rubin DT. Successful Treatment of Ulcerative Colitis With Vedolizumab in a Patient With an Infliximab-Associated Psoriasiform Rash. ACG Case Rep J. 2015 Jul; 2(4):236-8. PMID: 26203450; PMCID: PMC4508952.
      Citations:    
    348. Yarur AJ, Rubin DT. Therapeutic Drug Monitoring of Anti-tumor Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2015 Jul; 21(7):1709-18. PMID: 25901974.
      Citations: 25     Fields:    Translation:Humans
    349. Ali R, Wild D, Shieh F, Diehl DL, Fischer M, Tamura W, Rubin DT, Kumbhari V, Okolo P, Storm A, Halpern Z, Neumann H, Khara HS, Pochapin MB, Gross SA. Deep enteroscopy with a conventional colonoscope: initial multicenter study by using a through-the-scope balloon catheter system. Gastrointest Endosc. 2015 Nov; 82(5):855-60. PMID: 26092618.
      Citations: 14     Fields:    Translation:Humans
    350. Rubin DT. When Should Therapy for Inflammatory Bowel Disease Be Stopped? Gastroenterol Hepatol (N Y). 2015 Jun; 11(6):400-2. PMID: 27118934; PMCID: PMC4843034.
      Citations: 3     
    351. Rao VL, Micic D, Rubin DT. Hematochezia and a Mesenteric Mass. Gastroenterology. 2015 Jul; 149(1):e12-3. PMID: 26026749.
      Citations:    Fields:    Translation:Humans
    352. Bellaguarda E, Keyashian K, Pekow J, Rubin DT, Cohen RD, Sakuraba A. Prevalence of Antibodies Against JC Virus in Patients With Refractory Crohn's Disease and Effects of Natalizumab Therapy. Clin Gastroenterol Hepatol. 2015 Nov; 13(11):1919-25. PMID: 26001336; PMCID: PMC4795937.
      Citations: 10     Fields:    Translation:HumansCells
    353. Kelly CR, Kahn S, Kashyap P, Laine L, Rubin D, Atreja A, Moore T, Wu G. Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. Gastroenterology. 2015 Jul; 149(1):223-37. PMID: 25982290; PMCID: PMC4755303.
      Citations: 229     Fields:    Translation:HumansCells
    354. Rubin DT, Krugliak Cleveland N. Using a Treat-to-Target Management Strategy to Improve the Doctor-Patient Relationship in Inflammatory Bowel Disease. Am J Gastroenterol. 2015 Sep; 110(9):1252-6. PMID: 25848924.
      Citations: 16     Fields:    Translation:Humans
    355. Rubin DT, Kahn SA. Can we improve on the "see one, do one, teach one" paradigm in training fellows to care for patients with inflammatory bowel disease? Inflamm Bowel Dis. 2015 Apr; 21(4):766-7. PMID: 25719529.
      Citations:    Fields:    Translation:Humans
    356. Rubin DT. The rationale and growth of advanced training in inflammatory bowel disease. Gastroenterology. 2015 Apr; 148(4):696-700. PMID: 25724456.
      Citations: 7     Fields:    Translation:Humans
    357. Rubin DT. The Rationale and Growth of Advanced Training in Inflammatory Bowel Disease. Gastroenterology. 2015 Feb 04. PMID: 25659281.
      Citations:    Fields:    
    358. Colman RJ, Rubin DT. Optimal doses of methotrexate combined with anti-TNF therapy to maintain clinical remission in inflammatory bowel disease. J Crohns Colitis. 2015 Apr; 9(4):312-7. PMID: 25616487; PMCID: PMC4621545.
      Citations: 12     Fields:    Translation:Humans
    359. Coronel E, Micic D, Rubin DT. Patchy colitis and interstitial lung disease. Gastroenterology. 2015 Jan; 148(1):26-7. PMID: 25450070.
      Citations: 1     Fields:    Translation:Humans
    360. Rubin DT. Why it's time for updated U.S. colorectal cancer prevention guidelines in inflammatory bowel disease. Gastrointest Endosc. 2014 Nov; 80(5):849-51. PMID: 25436396.
      Citations: 2     Fields:    Translation:Humans
    361. Stein AC, Rubin DT, Hanauer SB, Cohen RD. Incidence and predictors of clinical response, re-induction dose, and maintenance dose escalation with certolizumab pegol in Crohn's disease. Inflamm Bowel Dis. 2014 Oct; 20(10):1722-8. PMID: 25171509.
      Citations: 6     Fields:    Translation:Humans
    362. Nannegari V, Roque S, Rubin DT, Quera R. A Review of Inflammatory Bowel Disease in the Setting of Liver Transplantation. Gastroenterol Hepatol (N Y). 2014 Oct; 10(10):626-30. PMID: 27540334; PMCID: PMC4988220.
      Citations: 4     
    363. Colman RJ, Rubin DT. Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis. 2014 12; 8(12):1569-81. PMID: 25223604; PMCID: PMC4296742.
      Citations: 195     Fields:    Translation:Humans
    364. Kahn SA, Goeppinger SR, Rubin DT. Fecal microbiota transplantation: an interest in IBD? Nestle Nutr Inst Workshop Ser. 2014; 79:101-14. PMID: 25227298.
      Citations:    Fields:    Translation:Humans
    365. Shah SA, Rubin DT, Farraye FA. Chromoendoscopy for colorectal cancer surveillance in patients with inflammatory bowel disease. Curr Gastroenterol Rep. 2014 Sep; 16(9):407. PMID: 25113042.
      Citations: 4     Fields:    Translation:Humans
    366. Stein AC, Appannagari A, Habib I, Semrad CE, Rubin DT. A rapid and accurate method to detect active small bowel gastrointestinal bleeding on video capsule endoscopy. Dig Dis Sci. 2014 Oct; 59(10):2503-7. PMID: 25146843.
      Citations: 3     Fields:    Translation:Humans
    367. Chapman CG, Rubin DT. The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease. Gastrointest Endosc Clin N Am. 2014 Jul; 24(3):353-65. PMID: 24975527; PMCID: PMC4165430.
      Citations: 8     Fields:    Translation:Humans
    368. Sofia MA, Rubin DT, Hou N, Pekow J. Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital. Dig Dis Sci. 2014 Sep; 59(9):2228-35. PMID: 24752402; PMCID: PMC4180597.
      Citations: 18     Fields:    Translation:Humans
    369. Chapman CG, Bochenek A, Stein AC, Rubin DT. Use of Serum Infliximab Level Prior to Cyclosporine Salvage Therapy in Severe Ulcerative Colitis. ACG Case Rep J. 2014 Apr; 1(3):148-50. PMID: 26157857; PMCID: PMC4435295.
      Citations: 3     
    370. Rubin DT, Mody R, Davis KL, Wang CC. Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease. Aliment Pharmacol Ther. 2014 May; 39(10):1143-55. PMID: 24697826.
      Citations: 41     Fields:    Translation:Humans
    371. Rubin DT, Becker S, Siegler M. Ethical considerations for clinical trials in inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2014 Jan; 10(1):37-41. PMID: 24799837; PMCID: PMC4008957.
      Citations: 5     
    372. Micic D, Rubin DT. Describing the clinical phenotypes of Crohn's disease: lessons from the past: commentary on: the broadening conception of regional ileitis. Dig Dis Sci. 2014 Jan; 59(1):6-8. PMID: 24374644.
      Citations:    Fields:    Translation:Humans
    373. Liao C, Fichera A, Rubin DT, Pekow J, Nelson R. Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis. Inflamm Bowel Dis. 2014 Jan; 20(1):14-20. PMID: 24297054; PMCID: PMC4017597.
      Citations: 22     Fields:    Translation:Humans
    374. Rubin DT. Introduction to the 80th anniversary issue of Digestive Diseases and Sciences. Dig Dis Sci. 2014 Jan; 59(1):2-5. PMID: 24370783.
      Citations:    Fields:    
    375. Kinnucan JA, Rubin DT, Ali T. Sleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammation. Gastroenterol Hepatol (N Y). 2013 Nov; 9(11):718-27. PMID: 24764789; PMCID: PMC3995194.
      Citations: 27     
    376. Sakuraba A, Annunziata ML, Cohen RD, Hanauer SB, Rubin DT. Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's disease. Inflamm Bowel Dis. 2013 Nov; 19(12):2577-83. PMID: 24132161.
      Citations: 11     Fields:    Translation:Humans
    377. Rubin DT, Goeppinger SR. Initial experience of a through-the-scope balloon device for ileal intubation in Crohn's disease. Gastrointest Endosc. 2013 Oct; 78(4):669-70. PMID: 24054746.
      Citations: 2     Fields:    Translation:Humans
    378. Rubin DT. Curbing our enthusiasm for fecal transplantation in ulcerative colitis. Am J Gastroenterol. 2013 Oct; 108(10):1631-3. PMID: 24091506.
      Citations: 11     Fields:    Translation:Humans
    379. Madhoun MF, Orr WC, Rubin DT, Ali T. Assessment of the relationship between quality of sleep and disease activity in inflammatory bowel disease patients. Inflamm Bowel Dis. 2013 Oct; 19(11):2440-3. PMID: 23945186.
      Citations: 62     Fields:    Translation:Humans
    380. Branas CC, Rubin D, Guo W. Vacant Properties and Violence in Neighborhoods. ISRN Public Health. 2013 Sep 10; 2012:246142. PMID: 23814668; PMCID: PMC3693396.
      Citations: 25     
    381. Weber CR, Rubin DT. Chronic pouchitis versus recurrent Crohn's disease: a diagnostic challenge. Dig Dis Sci. 2013 Oct; 58(10):2748-50. PMID: 23925821; PMCID: PMC3805823.
      Citations: 1     Fields:    Translation:Humans
    382. Rubin DT, Huo D, Kinnucan JA, Sedrak MS, McCullom NE, Bunnag AP, Raun-Royer EP, Cohen RD, Hanauer SB, Hart J, Turner JR. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. Clin Gastroenterol Hepatol. 2013 Dec; 11(12):1601-8.e1-4. PMID: 23872237; PMCID: PMC3840031.
      Citations: 100     Fields:    Translation:Humans
    383. Mikolajczyk AE, Rubin DT, McConville JF. A diagnosis that eats at you. Gastroenterology. 2013 Aug; 145(2):289, 489. PMID: 23810344.
      Citations: 1     Fields:    Translation:Humans
    384. Kahn SA, Vachon A, Rodriquez D, Goeppinger SR, Surma B, Marks J, Rubin DT. Patient perceptions of fecal microbiota transplantation for ulcerative colitis. Inflamm Bowel Dis. 2013 Jun; 19(7):1506-13. PMID: 23624888; PMCID: PMC3780382.
      Citations: 34     Fields:    Translation:Humans
    385. Rubin DT. What you see is not always what you get: raising the bar on clinical trial methodology in ulcerative colitis. Gastroenterology. 2013 Jul; 145(1):45-47. PMID: 23726879.
      Citations: 2     Fields:    Translation:Humans
    386. Chiu YL, Rubin DT, Vermeire S, Louis E, Robinson AM, Lomax KG, Pollack PF, Paulson SK. Serum adalimumab concentration and clinical remission in patients with Crohn's disease. Inflamm Bowel Dis. 2013 May; 19(6):1112-22. PMID: 23584130.
      Citations: 41     Fields:    Translation:Humans
    387. Sakuraba A, Keyashian K, Correia C, Melek J, Cohen RD, Hanauer SB, Rubin DT. Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center. Inflamm Bowel Dis. 2013 Mar; 19(3):621-6. PMID: 23429449; PMCID: PMC4779049.
      Citations: 13     Fields:    Translation:Humans
    388. Melmed GY, Siegel CA, Spiegel BM, Allen JI, Cima R, Colombel JF, Dassopoulos T, Denson LA, Dudley-Brown S, Garb A, Hanauer SB, Kappelman MD, Lewis JD, Lynch I, Moynihan A, Rubin DT, Sartor RB, Schwartz RM, Wolf DC, Ullman TA. Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis. 2013 Mar; 19(3):662-8. PMID: 23388547.
      Citations: 57     Fields:    Translation:Humans
    389. McKeag H, Christian CW, Rubin D, Daymont C, Pollock AN, Wood J. Subdural hemorrhage in pediatric patients with enlargement of the subarachnoid spaces. J Neurosurg Pediatr. 2013 Apr; 11(4):438-44. PMID: 23394356; PMCID: PMC8502493.
      Citations: 17     Fields:    Translation:Humans
    390. Hoentjen F, Seinen ML, Hanauer SB, de Boer NK, Rubin DT, Bouma G, Harrell LE, van Bodegraven AA. Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis. 2013 Feb; 19(2):363-9. PMID: 22605661.
      Citations: 30     Fields:    Translation:HumansCTClinical Trials
    391. Kisiel JB, Yab TC, Nazer Hussain FT, Taylor WR, Garrity-Park MM, Sandborn WJ, Loftus EV, Wolff BG, Smyrk TC, Itzkowitz SH, Rubin DT, Zou H, Mahoney DW, Ahlquist DA. Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013 Mar; 37(5):546-54. PMID: 23347191; PMCID: PMC3869396.
      Citations: 40     Fields:    Translation:Humans
    392. Hoentjen F, Hanauer SB, Hart J, Rubin DT. Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy. J Clin Gastroenterol. 2013 Jan; 47(1):52-7. PMID: 22858512; PMCID: PMC3874322.
      Citations: 11     Fields:    Translation:Humans
    393. Erichsen D, Godoy C, Axelsson J, Rubin D, Gozal D, Gränse F. Screening for sleep disorders in pediatric primary care: are we there yet? Clin Pediatr (Phila). 2012 Dec; 51(12):1125-9. PMID: 23203980.
      Citations: 12     Fields:    Translation:HumansPHPublic Health
    394. Kahn SA, Young S, Rubin DT. Colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection in a child. Am J Gastroenterol. 2012 Dec; 107(12):1930-1. PMID: 23211865.
      Citations: 13     Fields:    Translation:HumansCells
    395. Mahadevan U, Wolf DC, Dubinsky M, Cortot A, Lee SD, Siegel CA, Ullman T, Glover S, Valentine JF, Rubin DT, Miller J, Abreu MT. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013 Mar; 11(3):286-92; quiz e24. PMID: 23200982; PMCID: PMC3913646.
      Citations: 101     Fields:    Translation:Humans
    396. Hanauer SB, Rubin DT. In memoriam. Inflamm Bowel Dis. 2012 Nov; 18(11):2001-3. PMID: 23070951.
      Citations:    Fields:    Translation:Humans
    397. Hanauer SB, Rubin DT. Joseph Barnett Kirsner, MD, PhD. Dig Dis Sci. 2012 Nov; 57(11):2722-4. PMID: 23236606.
      Citations:    Fields:    Translation:Humans
    398. Hanauer SB, Rubin DT. Joseph Barnett Kirsner, MD, PhD. Clin Gastroenterol Hepatol. 2012 Nov; 10(11):1181-2. PMID: 23084570.
      Citations:    Fields:    Translation:Humans
    399. Hanauer SB, Rubin D. Joseph Barnett Kirsner, MD, PhD. Gastrointest Endosc. 2012 Oct; 76(4):730-2. PMID: 22985640.
      Citations:    Fields:    
    400. Hanauer SB, Rubin DT. In memoriam: Dr Joseph Barnett Kirsner. Gut. 2012 Nov; 61(11):1636-7. PMID: 22976043.
      Citations:    Fields:    Translation:Humans
    401. Henderson TO, Oeffinger KC, Whitton J, Leisenring W, Neglia J, Meadows A, Crotty C, Rubin DT, Diller L, Inskip P, Smith SA, Stovall M, Constine LS, Hammond S, Armstrong GT, Robison LL, Nathan PC. Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study. Ann Intern Med. 2012 Jun 05; 156(11):757-66, W-260. PMID: 22665813; PMCID: PMC3554254.
      Citations: 65     Fields:    Translation:HumansPHPublic Health
    402. Henderson TO, Oeffinger KC, Whitton J, Leisenring W, Neglia J, Meadows A, Crotty C, Rubin DT, Diller L, Inskip P, Smith SA, Stovall M, Constine LS, Hammond S, Armstrong GT, Robison LL, Nathan PC. Summaries for patients. Increased risk for gastrointestinal cancer in childhood cancer survivors. Ann Intern Med. 2012 Jun 05; 156(11):I-36. PMID: 22665822.
      Citations:    Fields:    Translation:HumansPHPublic Health
    403. Rubin DT, Uluscu O, Sederman R. Response to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims data. Inflamm Bowel Dis. 2012 Dec; 18(12):2225-31. PMID: 22359399.
      Citations: 32     Fields:    Translation:Humans
    404. Leung Y, Kaplan GG, Rioux KP, Hubbard J, Kamhawi S, Stasiak L, Cohen RD, Devlin SM, Panaccione R, Hanauer SB, Rubin DT. Assessment of variables associated with smoking cessation in Crohn's disease. Dig Dis Sci. 2012 Apr; 57(4):1026-32. PMID: 22311366.
      Citations: 8     Fields:    Translation:Humans
    405. Ali T, Yun L, Rubin DT. Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease. World J Gastroenterol. 2012 Jan 21; 18(3):197-204. PMID: 22294822; PMCID: PMC3261536.
      Citations: 13     Fields:    Translation:Humans
    406. Calabrese E, Yanai H, Shuster D, Rubin DT, Hanauer SB. Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis. J Crohns Colitis. 2012 Aug; 6(7):756-62. PMID: 22398093.
      Citations: 14     Fields:    Translation:Humans
    407. Hoentjen F, Hanauer SB, de Boer NK, Rubin DT. Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction. Dig Dis Sci. 2012 Jan; 57(1):250-3. PMID: 22147254; PMCID: PMC3253335.
      Citations: 1     Fields:    Translation:Humans
    408. Rubin DT, Sohi S, Glathar M, Thomas T, Yadron N, Surma BL. Rifaximin Is Effective for the Treatment of Clostridium difficile-Associated Diarrhea: Results of an Open-Label Pilot Study. Gastroenterol Res Pract. 2011; 2011:106978. PMID: 22114587; PMCID: PMC3216319.
      Citations: 12     
    409. Hoentjen F, Rubin DT. Infectious proctitis: when to suspect it is not inflammatory bowel disease. Dig Dis Sci. 2012 Feb; 57(2):269-73. PMID: 21994137.
      Citations: 17     Fields:    Translation:HumansCells
    410. Fichera A, Zoccali M, Felice C, Rubin DT. Total abdominal colectomy for refractory ulcerative colitis. Surgical treatment in evolution. J Gastrointest Surg. 2011 Nov; 15(11):1909-16. PMID: 21909842.
      Citations: 7     Fields:    Translation:Humans
    411. Rubin DT, Mulani P, Chao J, Pollack PF, Bensimon AG, Yu AP, Ghosh S. Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: results from the CHARM trial. Inflamm Bowel Dis. 2012 May; 18(5):818-25. PMID: 21887727.
      Citations: 7     Fields:    Translation:Humans
    412. Rubin DT, Panaccione R, Chao J, Robinson AM. A practical, evidence-based guide to the use of adalimumab in Crohn's disease. Curr Med Res Opin. 2011 Sep; 27(9):1803-13. PMID: 21809894.
      Citations: 3     Fields:    Translation:Humans
    413. Kahn SA, Gorawara-Bhat R, Rubin DT. Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we? Inflamm Bowel Dis. 2012 Apr; 18(4):676-84. PMID: 21618362; PMCID: PMC3183116.
      Citations: 27     Fields:    Translation:Humans
    414. Pekow JR, Dougherty U, Mustafi R, Zhu H, Kocherginsky M, Rubin DT, Hanauer SB, Hart J, Chang EB, Fichera A, Joseph LJ, Bissonnette M. miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes. Inflamm Bowel Dis. 2012 Jan; 18(1):94-100. PMID: 21557394; PMCID: PMC3931730.
      Citations: 54     Fields:    Translation:HumansCells
    415. St Jacques PL, Kragel PA, Rubin DC. Dynamic neural networks supporting memory retrieval. Neuroimage. 2011 Jul 15; 57(2):608-16. PMID: 21550407; PMCID: PMC3114167.
      Citations: 45     Fields:    Translation:Humans
    416. Cohen RD, Lewis JR, Turner H, Harrell LE, Hanauer SB, Rubin DT. Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center. Inflamm Bowel Dis. 2012 Jan; 18(1):10-6. PMID: 21456032.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    417. Rubin DT. We once were blind and now we see: is it time to treat ulcerative colitis to achieve mucosal healing? Clin Gastroenterol Hepatol. 2011 Jun; 9(6):456-7. PMID: 21421077.
      Citations: 6     Fields:    Translation:Humans
    418. Oto A, Kayhan A, Williams JT, Fan X, Yun L, Arkani S, Rubin DT. Active Crohn's disease in the small bowel: evaluation by diffusion weighted imaging and quantitative dynamic contrast enhanced MR imaging. J Magn Reson Imaging. 2011 Mar; 33(3):615-24. PMID: 21563245.
      Citations: 65     Fields:    Translation:HumansCells
    419. Kappelman MD, Horvath-Puho E, Sandler RS, Rubin DT, Ullman TA, Pedersen L, Baron JA, Sørensen HT. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut. 2011 Jul; 60(7):937-43. PMID: 21339206.
      Citations: 86     Fields:    Translation:Humans
    420. Lichtenstein GR, Ramsey D, Rubin DT. Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing--ASCEND I and II combined analysis. Aliment Pharmacol Ther. 2011 Mar; 33(6):672-8. PMID: 21255059.
      Citations: 27     Fields:    Translation:Humans
    421. Hanauer SB, Kornbluth AA, Messick J, Rubin DT, Sandborn WJ, Sands BE. Clinical scenarios in IBD: optimizing the use of conventional and biologic agents. Inflamm Bowel Dis. 2010 Dec; 16 Suppl 1:S1-11. PMID: 21104734.
      Citations: 8     Fields:    Translation:Humans
    422. Rubin DT, Rothe JA. The peri-appendiceal red patch in ulcerative colitis: review of the University of Chicago experience. Dig Dis Sci. 2010 Dec; 55(12):3495-501. PMID: 20936357.
      Citations: 13     Fields:    Translation:Humans
    423. Siegel CA, Schwartz LM, Woloshin S, Cole EB, Rubin DT, Vay T, Baars J, Sands BE. When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations. Inflamm Bowel Dis. 2010 Oct; 16(10):1658-62. PMID: 20186940; PMCID: PMC2927807.
      Citations: 16     Fields:    Translation:HumansPHPublic Health
    424. Pekow JR, Hetzel JT, Rothe JA, Hanauer SB, Turner JR, Hart J, Noffsinger A, Huo D, Rubin DT. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Inflamm Bowel Dis. 2010 Aug; 16(8):1352-6. PMID: 20027656; PMCID: PMC3046461.
      Citations: 25     Fields:    Translation:HumansPHPublic Health
    425. Rosenberg JA, Rubin DT. Performance of CT colonography in clinical trials. Gastrointest Endosc Clin N Am. 2010 Apr; 20(2):193-207. PMID: 20451810.
      Citations:    Fields:    Translation:HumansPHPublic Health
    426. Kappelman MD, Palmer L, Boyle BM, Rubin DT. Quality of care in inflammatory bowel disease: a review and discussion. Inflamm Bowel Dis. 2010 Jan; 16(1):125-33. PMID: 19572335.
      Citations: 29     Fields:    Translation:Humans
    427. Zisman TL, Rubin DT. Novel diagnostic and prognostic modalities in inflammatory bowel disease. Med Clin North Am. 2010 Jan; 94(1):155-78. PMID: 19944803.
      Citations: 2     Fields:    
    428. Zisman TL, Rubin DT. Novel diagnostic and prognostic modalities in inflammatory bowel disease. Gastroenterol Clin North Am. 2009 Dec; 38(4):729-52. PMID: 19913211.
      Citations: 3     Fields:    Translation:Humans
    429. Rubin DT, Gandhi RK, Hetzel JT, Kinnear SH, Aronsohn A, Wood G, Yadron N. Do colorectal cancer patients understand that their family is at risk? Dig Dis Sci. 2009 Nov; 54(11):2473-83. PMID: 19731030.
      Citations: 5     Fields:    Translation:Humans
    430. Rubin DT, Dubinsky MC, Panaccione R, Siegel CA, Binion DG, Kane SV, Hopper J. The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey. Dig Dis Sci. 2010 Apr; 55(4):1044-52. PMID: 20155319.
      Citations: 20     Fields:    Translation:Humans
    431. Afif W, Leighton JA, Hanauer SB, Loftus EV, Faubion WA, Pardi DS, Tremaine WJ, Kane SV, Bruining DH, Cohen RD, Rubin DT, Hanson KA, Sandborn WJ. Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab. Inflamm Bowel Dis. 2009 Sep; 15(9):1302-7. PMID: 19408340.
      Citations: 39     Fields:    Translation:HumansCTClinical Trials
    432. Lewis JR, Konda V, Rubin DT. Genetic testing for inflammatory bowel disease: focus group analysis of patients and family members. Genet Test Mol Biomarkers. 2009 Aug; 13(4):495-503. PMID: 19580441.
      Citations: 7     Fields:    Translation:Humans
    433. Bezabeh T, Somorjai R, Dolenko B, Bryskina N, Levin B, Bernstein CN, Jeyarajah E, Steinhart AH, Rubin DT, Smith IC. Detecting colorectal cancer by 1H magnetic resonance spectroscopy of fecal extracts. NMR Biomed. 2009 Jul; 22(6):593-600. PMID: 19259992.
      Citations: 20     Fields:    Translation:Humans
    434. Huo D, Hetzel JT, Roy H, Rubin DT. Association of colorectal cancer and prostate cancer and impact of radiation therapy. Cancer Epidemiol Biomarkers Prev. 2009 Jul; 18(7):1979-85. PMID: 19531678.
      Citations: 15     Fields:    Translation:Humans
    435. Oto A, Fan X, Mustafi D, Jansen SA, Karczmar GS, Rubin DT, Kayhan A. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study. Acad Radiol. 2009 Oct; 16(10):1223-30. PMID: 19524458.
      Citations: 12     Fields:    Translation:Humans
    436. Hanauer SB, Present DH, Rubin DT. Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes. Gastroenterol Hepatol (N Y). 2009 Jun; 5(6 Suppl):4-16. PMID: 20574506; PMCID: PMC2886411.
      Citations: 4     
    437. Rubin DT, Surma BL, Gavzy SJ, Schnell KM, Bunnag AP, Huo D, Appelbaum DE. Positron emission tomography (PET) used to image subclinical inflammation associated with ulcerative colitis (UC) in remission. Inflamm Bowel Dis. 2009 May; 15(5):750-5. PMID: 19090558.
      Citations: 11     Fields:    Translation:Humans
    438. Rubin DT, Siegel CA, Kane SV, Binion DG, Panaccione R, Dubinsky MC, Loftus EV, Hopper J. Impact of ulcerative colitis from patients' and physicians' perspectives: Results from the UC: NORMAL survey. Inflamm Bowel Dis. 2009 Apr; 15(4):581-8. PMID: 19067414.
      Citations: 36     Fields:    Translation:Humans
    439. Silverberg MS, Rubin DT, Steinhart AH, Cohen LB, Rotter JI. Israel-Gaza conflict. Lancet. 2009 Mar 14; 373(9667):891-2. PMID: 19286075.
      Citations:    Fields:    Translation:Humans
    440. Kim K, Velez I, Rubin D. A rare case of granulocytic sarcoma in the mandible of a 4-year-old child: a case report and review of the literature. J Oral Maxillofac Surg. 2009 Feb; 67(2):410-6. PMID: 19138619.
      Citations: 4     Fields:    Translation:Humans
    441. Higgins PD, Rubin DT, Kaulback K, Schoenfield PS, Kane SV. Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. Aliment Pharmacol Ther. 2009 Feb 01; 29(3):247-57. PMID: 18945258.
      Citations: 52     Fields:    Translation:Humans
    442. Loftus EV, Feagan BG, Rubin DT, Wu EQ, Yu AP, Pollack PF, Chao J, Mulani P, Colombel JF. Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial. Am J Gastroenterol. 2008 Dec; 103(12):3132-41. PMID: 18853973.
      Citations: 59     Fields:    Translation:HumansCTClinical Trials
    443. Nathanson JW, Zisman TL, Julian C, McCaffrey S, Rubin DT. Identification of patients at increased risk for colorectal cancer in an open access endoscopy center. J Clin Gastroenterol. 2008 Oct; 42(9):1025-31. PMID: 18719509.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    444. Rubin DT. An updated approach to dysplasia in IBD. J Gastrointest Surg. 2008 Dec; 12(12):2153-6. PMID: 18766409.
      Citations:    Fields:    Translation:Humans
    445. Weber CR, Nalle SC, Tretiakova M, Rubin DT, Turner JR. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest. 2008 Oct; 88(10):1110-20. PMID: 18711353; PMCID: PMC2586671.
      Citations: 177     Fields:    Translation:HumansCells
    446. Calderwood AH, Huo D, Rubin DT. Association between colorectal cancer and urologic cancers. Arch Intern Med. 2008 May 12; 168(9):1003-9. PMID: 18474765.
      Citations: 13     Fields:    Translation:Humans
    447. Zisman TL, Rubin DT. Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol. 2008 May 07; 14(17):2662-9. PMID: 18461651; PMCID: PMC2709054.
      Citations: 50     Fields:    Translation:HumansPHPublic Health
    448. Herrerias JM, Leighton JA, Costamagna G, Infantolino A, Eliakim R, Fischer D, Rubin DT, Manten HD, Scapa E, Morgan DR, Bergwerk AJ, Koslowsky B, Adler SN. Agile patency system eliminates risk of capsule retention in patients with known intestinal strictures who undergo capsule endoscopy. Gastrointest Endosc. 2008 May; 67(6):902-9. PMID: 18355824.
      Citations: 60     Fields:    Translation:HumansPHPublic Health
    449. Rubin DT, Cruz-Correa MR, Gasche C, Jass JR, Lichtenstein GR, Montgomery EA, Riddell RH, Rutter MD, Ullman TA, Velayos FS, Itzkowitz S, 5-ASA in Colorectal Cancer Prevention Meeting Group. Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update. Inflamm Bowel Dis. 2008 Feb; 14(2):265-74. PMID: 17932965.
      Citations: 24     Fields:    Translation:Humans
    450. Kane SV, Brixner D, Rubin DT, Sewitch MJ. The challenge of compliance and persistence: focus on ulcerative colitis. J Manag Care Pharm. 2008 Jan; 14(1 Suppl A):s2-12; quiz s13-5. PMID: 18240888; PMCID: PMC10438168.
      Citations: 19     Fields:    Translation:Humans
    451. Lichtenstein GR, Rubin DT, Sabesin SM, Velayos FS, Vitat P. Maximizing patient adherence and clinical outcomes with mesalamine in mildly-to-moderately active ulcerative colitis. Rev Gastroenterol Disord. 2008; 8(1):21-30; quiz 31-2. PMID: 18477967.
      Citations: 1     Fields:    Translation:Humans
    452. Dugdale LS, Siegler M, Rubin DT. Medical professionalism and the doctor-patient relationship. Perspect Biol Med. 2008; 51(4):547-53. PMID: 18997357.
      Citations: 5     Fields:    Translation:Humans
    453. Dalal A, Urban C, Ahluwalia M, Rubin D. Corynebacterium bovis line related septicemia: a case report and review of the literature. Scand J Infect Dis. 2008; 40(6-7):575-7. PMID: 18584551.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    454. Nathanson JW, Yadron NE, Farnan J, Kinnear S, Hart J, Rubin DT. p53 mutations are associated with dysplasia and progression of dysplasia in patients with Crohn's disease. Dig Dis Sci. 2008 Feb; 53(2):474-80. PMID: 17676397.
      Citations: 10     Fields:    Translation:Humans
    455. Rubin DT, Ulitsky A, Poston J, Day R, Huo D. What is the most effective way to communicate results after endoscopy? Gastrointest Endosc. 2007 Jul; 66(1):108-12. PMID: 17591482.
      Citations: 8     Fields:    Translation:Humans
    456. Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc. 2007 Jun; 65(7):998-1004. PMID: 17451704.
      Citations: 53     Fields:    Translation:HumansPHPublic Health
    457. Terdiman JP, Steinbuch M, Blumentals WA, Ullman TA, Rubin DT. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2007 Apr; 13(4):367-71. PMID: 17206695.
      Citations: 38     Fields:    Translation:Humans
    458. LoSavio AD, Bunnag AP, Rubin DT. Colonic infiltration with chronic myelomonocytic leukemia. Nat Clin Pract Gastroenterol Hepatol. 2007 Apr; 4(4):229-33. PMID: 17404590.
      Citations: 2     Fields:    Translation:Humans
    459. Cummings SA, Rubin DT. The complexity and challenges of genetic counseling and testing for inflammatory bowel disease. J Genet Couns. 2006 Dec; 15(6):465-76. PMID: 17106630.
      Citations: 3     Fields:    Translation:Humans
    460. Kupfer SS, Rubin DT. Inflammatory Bowel Disease and Cerebral Venous Sinus Thrombosis. Gastroenterol Hepatol (N Y). 2006 Dec; 2(12):914-917. PMID: 28331482; PMCID: PMC5359939.
      Citations: 5     
    461. Rubin DT, Turner JR. Surveillance of dysplasia in inflammatory bowel disease: The gastroenterologist-pathologist partnership. Clin Gastroenterol Hepatol. 2006 Nov; 4(11):1309-13. PMID: 17110299; PMCID: PMC1829445.
      Citations: 11     Fields:    Translation:Humans
    462. Rubin DT, LoSavio A, Yadron N, Huo D, Hanauer SB. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis. Clin Gastroenterol Hepatol. 2006 Nov; 4(11):1346-50. PMID: 17059900.
      Citations: 35     Fields:    Translation:Humans
    463. Dachman AH, Dawson DO, Lefere P, Yoshida H, Khan NU, Cipriani N, Rubin DT. Comparison of routine and unprepped CT colonography augmented by low fiber diet and stool tagging: a pilot study. Abdom Imaging. 2007 Jan-Feb; 32(1):96-104. PMID: 16969601.
      Citations: 8     Fields:    Translation:Humans
    464. Rubin DT, Kavitt RT. Surveillance for cancer and dysplasia in inflammatory bowel disease. Gastroenterol Clin North Am. 2006 Sep; 35(3):581-604. PMID: 16952742.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    465. Bosworth HB, Rockey DC, Paulson EK, Niedzwiecki D, Davis W, Sanders LL, Yee J, Henderson J, Hatten P, Burdick S, Sanyal A, Rubin DT, Sterling M, Akerkar G, Bhutani MS, Binmoeller K, Garvie J, Bini EJ, McQuaid K, Foster WL, Thompson WM, Dachman A, Halvorsen R. Prospective comparison of patient experience with colon imaging tests. Am J Med. 2006 Sep; 119(9):791-9. PMID: 16945615.
      Citations: 17     Fields:    Translation:Humans
    466. Rubin DT, Sohi S, Shilling RA, White SR. Pulmonary Eosinophilia Following Infliximab Treatment for Crohn's Disease. Gastroenterol Hepatol (N Y). 2006 Aug; 2(8):592-596. PMID: 28316528; PMCID: PMC5350253.
      Citations: 2     
    467. Konda V, Huo D, Hermes G, Liu M, Patel R, Rubin DT. Do patients with inflammatory bowel disease want genetic testing? Inflamm Bowel Dis. 2006 Jun; 12(6):497-502. PMID: 16775494.
      Citations: 5     Fields:    Translation:Humans
    468. Rubin DT, Parekh N. Colorectal cancer in inflammatory bowel disease: molecular and clinical considerations. Curr Treat Options Gastroenterol. 2006 Jun; 9(3):211-20. PMID: 16901385.
      Citations: 9     
    469. Rubin DT. Genetic Testing in IBD Patients. Gastroenterol Hepatol (N Y). 2006 May; 2(5):342-344. PMID: 28289337; PMCID: PMC5338187.
      Citations:    
    470. Rubin DT. The changing face of colorectal cancer in inflammatory bowel disease: progress at last! Gastroenterology. 2006 Apr; 130(4):1350-2. PMID: 16618426.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    471. Jahraus CD, Rubin DT, Scherl EJ, Bettenhausen D. Inflammation's role in rectal cancer following prostate radiotherapy, and emerging evidence for a protective role for balsalazide. Gastroenterology. 2005 Aug; 129(2):770-2. PMID: 16083743.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    472. Rubin DT, Lashner BA. Will a 5-ASA a day keep the cancer (and dysplasia) away? Am J Gastroenterol. 2005 Jun; 100(6):1354-6. PMID: 15929769.
      Citations: 4     Fields:    Translation:Humans
    473. Ross AS, Gasparaitis A, Hurst R, Hanauer SB, Rubin DT. Superior mesenteric vein thrombosis after colectomy in a patient with Crohn's disease. Nat Clin Pract Gastroenterol Hepatol. 2005 Jun; 2(6):281-5; quiz 1 p following 285. PMID: 16265232.
      Citations: 3     Fields:    Translation:Humans
    474. Rubin DT. To test or "NOD-2" test: what are the questions? The balanced viewpoint. Inflamm Bowel Dis. 2005 May; 11(5):510-2. PMID: 15867593.
      Citations: 2     Fields:    Translation:Humans
    475. Rubin DT, Kornblunth A. Role of antibiotics in the management of inflammatory bowel disease: a review. Rev Gastroenterol Disord. 2005; 5 Suppl 3:S10-5. PMID: 17713454.
      Citations: 3     Fields:    Translation:Humans
    476. Rockey DC, Paulson E, Niedzwiecki D, Davis W, Bosworth HB, Sanders L, Yee J, Henderson J, Hatten P, Burdick S, Sanyal A, Rubin DT, Sterling M, Akerkar G, Bhutani MS, Binmoeller K, Garvie J, Bini EJ, McQuaid K, Foster WL, Thompson WM, Dachman A, Halvorsen R. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet. 2005 Jan 22-28; 365(9456):305-11. PMID: 15664225.
      Citations: 120     Fields:    Translation:Humans
    477. Harrell LE, Rubin DT, Hanauer SB. Fever and right upper quadrant pain in a pregnant woman at 30 weeks' gestation. Nat Clin Pract Gastroenterol Hepatol. 2004 Dec; 1(2):113-6; quiz 1 p following 116. PMID: 16265073.
      Citations: 1     Fields:    Translation:Humans
    478. Groeger JS, Weiser MA, Lederberg MS, Rubin DT, Siegler M. The case: can doctors say "enough"? Camb Q Healthc Ethics. 2003; 12(2):215-23. PMID: 12764890.
      Citations:    Fields:    Translation:Humans
    479. Yoshida H, MacEneaney P, Rubin DT, Dachman AH, Näppi J. Computer-aided diagnosis scheme for detection of polyps at CT colonography. Radiographics. 2002 Jul-Aug; 22(4):963-79. PMID: 12110726.
      Citations: 29     Fields:    Translation:Humans
    480. Yoshida H, Masutani Y, MacEneaney P, Rubin DT, Dachman AH. Computerized detection of colonic polyps at CT colonography on the basis of volumetric features: pilot study. Radiology. 2002 Feb; 222(2):327-36. PMID: 11818596.
      Citations: 28     Fields:    Translation:Humans
    481. Hannan EL, Radzyner M, Rubin D, Dougherty J, Brennan MF. The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery. 2002 Jan; 131(1):6-15. PMID: 11812957.
      Citations: 100     Fields:    Translation:Humans
    482. McConville JF, Rubin DT, Humphrey H, Carson SS. Effects of billing and documentation requirements on the quantity and quality of teaching by attending physicians. Acad Med. 2001 Nov; 76(11):1144-7. PMID: 11704518.
      Citations: 3     Fields:    Translation:Humans
    483. Rubin DT, Dachman AH. Virtual colonoscopy: a novel imaging modality for colorectal cancer. Curr Oncol Rep. 2001 Mar; 3(2):88-93. PMID: 11177739.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    484. Ehrenpreis ED, Rubin DT, Ginsburg PM, Meyers JS. Treatment of anal fissures with topical nitroglycerin. Expert Opin Pharmacother. 2001 Jan; 2(1):41-5. PMID: 11336567.
      Citations: 1     Fields:    Translation:Humans
    485. Ginsburg PM, Janefalkar P, Rubin DT, Ehrenpreis ED. Malabsorption testing: a review. Curr Gastroenterol Rep. 2000 Oct; 2(5):370-7. PMID: 10998664.
      Citations:    Fields:    Translation:Humans
    486. Rubin DT, Hanauer SB. Smoking and inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2000 Aug; 12(8):855-62. PMID: 10958212.
      Citations: 33     Fields:    Translation:Humans
    487. San Agustin M, Cohen P, Rubin D, Cleary SD, Erickson CJ, Allen JK. The Montefiore community children's project: a controlled study of cognitive and emotional problems of homeless mothers and children. J Urban Health. 1999 Mar; 76(1):39-50. PMID: 10091189; PMCID: PMC3456713.
      Citations: 10     Fields:    Translation:Humans
    488. Dachman AH, Kuniyoshi JK, Boyle CM, Samara Y, Hoffmann KR, Rubin DT, Hanan I. CT colonography with three-dimensional problem solving for detection of colonic polyps. AJR Am J Roentgenol. 1998 Oct; 171(4):989-95. PMID: 9762982.
      Citations: 25     Fields:    Translation:Humans
    489. Ross LF, Rubin DT, Siegler M, Josephson MA, Thistlethwaite JR, Woodle ES. Ethics of a paired-kidney-exchange program. N Engl J Med. 1997 Jun 12; 336(24):1752-5. PMID: 9180096.
      Citations: 21     Fields:    Translation:Humans
    490. Mooteri S, Rubin D, Leurgans S, Jakate S, Drab E, Saclarides T. Tumor angiogenesis in primary and metastatic colorectal cancers. Dis Colon Rectum. 1996 Oct; 39(10):1073-80. PMID: 8831518.
      Citations: 10     Fields:    Translation:Humans
    491. Young SW, Qing F, Rubin D, Balkus KJ, Engel JS, Lang J, Dow WC, Mutch JD, Miller RA. Gadolinium zeolite as an oral contrast agent for magnetic resonance imaging. J Magn Reson Imaging. 1995 Sep-Oct; 5(5):499-508. PMID: 8574032.
      Citations: 7     Fields:    Translation:HumansAnimalsCTClinical Trials
    492. Okuyama S, Rubin D, Woodley M, Peters MG. Regional expression of murine intestinal immune cells in normal and isografted intestine. Cell Immunol. 1995 Jul; 163(2):198-205. PMID: 7606793.
      Citations:    Fields: